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Abstract Respiratory syncytial virus is the leading cause of lower respiratory tract infection12
among infants. RSV is a priority for vaccine development. In this study, we investigate the potential13
effectiveness of a two-vaccine strategy aimed at mothers-to-be, thereby boosting maternally14
acquired antibodies of infants, and their household cohabitants, further cocooning infants against15
infection. We use a dynamic RSV transmission model which captures transmission both within16
households and communities, adapted to the changing demographics and RSV seasonality of a17
low-income country. Model parameters were inferred from past RSV hospitalisations, and forecasts18
made over a 10-year horizon. We find that a 50% reduction in RSV hospitalisations is possible if the19
maternal vaccine effectiveness can achieve 75 days of additional protection for newborns20
combined with a 75% coverage of their birth household co-inhabitants (∼7.5% population21
coverage).22
23
Introduction24
Respiratory syncytial virus (RSV) is the most common viral cause of acute lower respiratory infection25
Nair et al. (2010). A large majority of children contract RSV by the age of two Glezen et al. (1986);26
Ohuma et al. (2012) but the chance of developing severe disease from a RSV infection is much27
greater amongst young infants (<6 months) Hall et al. (2009) and decreases rapidly with the age of28
the infected child. Vaccine development aimed at protecting young children against RSV disease29
has become a global health priorityWorld Health Organization (2017). As of December 2018 there30
are over 40 RSV vaccines in development PATH (2018). In particular, two vaccination approaches31
have been identified as potentially effective: a single dose vaccine aimed at mothers-to-be leading32
to antibody transfer across the placenta thereby boosting maternally acquired immunity among33
newborns, and paediatric vaccination aimed directly at infantsModjarrad et al. (2016);World Health34
Organization (2017). Moreover, it is possible that a prophylactic extended half-life monoclonal35
antibody could act as a vaccine surrogate whilst replicating the desired effect of a maternal vaccine36
Zhu et al. (2017); Domachowske et al. (2018). A serious complication in RSV vaccine development37
has historically been the risk of causing enhanced disease amongst the immunologically naive Chin38
et al. (1969), therefore it might be more prudent to target a paediatric vaccine at older children with39
better developed immune systems rather than young infants most at risk of RSV disease Anderson40
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et al. (2013). Epidemiological data suggests older individuals (elder siblings, parents) are potential41
sources of infection for the infant of the household Graham (2014), for whom temporary boosted42
immunity might best be achieved using a sub-unit vaccine Anderson et al. (2013).43
The desired effect of vaccinating older children is two-fold: the vaccine both decreases the44
risk of morbidity in the vaccinated child and reduces the risk of transmission from the older child45
to any young infant the vaccinated child contacts Anderson et al. (2013). Molecular analysis of46
nasopharyngeal samples collected from a semi-rural community in Kenya has identified that the47
majority of RSV infections among young infants originated from within their household rather than48
the wider community, with older siblings being the usual household index case Munywoki et al.49
(2014), echoing a previous household study of RSV transmission Hall et al. (1976), although it should50
also be noted that the young infant was herself the index case on a significant number of occasions.51
This finding emphasises that reducing transmission to young infants within the household could be52
an effective way of reducing RSV disease in low- and middle-income countries (LMICs). However, the53
significant number of young infant index cases within households suggest that ‘cocooning’ young54
infants from transmission by vaccinating others in their household may not be sufficient by itself.55
Ideally, cocoon protection should be achieved in conjunction with directly protecting the young56
infants using a maternal vaccine.57
At this time, the only reported phase III trial on RSV vaccine effectiveness is for the maternally58
targeted ResVax®, which failed to meet its primary objective but nonetheless showed partial effec-59
tiveness at reducing hospitalisations due to RSV NovaVax (2019). The possibility that a vaccine for60
only one target population might be only partially effective, and the importance of RSV transmission61
within the household, motivates our modelling approach. In this paper we assess the efficacy of62
a mixed vaccination strategy in a LMIC setting, Kilifi county Kenya. In our scenarios there was at63
least one maternal vaccine and one paediatric vaccine available as per WHO priorityWorld Health64
Organization (2017). In Kenya there are very high rates of antenatal contact between pregnant65
women and health professionals (97.5% in Kilifi county; KNBS (2015)). This suggested targeting66
pregnant women as part of their antenatal contact, and then offering the paediatric vaccine to67
all over one year olds, including adults, cohabiting with the pregnant mother. The essential idea68
was to leverage antenatal contact to achieve a very high coverage of a maternal antibody boosting69
(MAB) vaccine, and also to target her household cohabitants with an immune response provoking70
(IRP) vaccine. The IRP vaccine elicits an immune response and, therefore, a temporary reduction71
in susceptibility to RSV for the vaccinated individual. We follow Yamin et al Yamin et al. (2016) in72
assuming that the elicited period of immunity to RSV from receiving the IRP vaccine would be similar73
to that of a natural infection.74
Predictions of vaccine effect are derived from a dynamic transmission model designed to75
capture the demographic structure of the population, the seasonality of RSV transmission and how76
rapidly, and to whom, RSV is transmitted in both households and the wider community. Unknown77
model parameters were inferred using data from the large-scale long-running Kilifi Health and78
Demographic Surveillance System (KHDSS; Scott et al. (2012)), and hospitalisation admissions at79
Kilifi county hospital (KCH) confirmed as due to RSV since 2002. It should be noted that targeting80
vaccination in this way is not an approach that one would expect to greatly reduce RSV infections81
under the assumptions of simple compartmental models of RSV transmission because the rate of82
vaccination deployment would be too low (see Box 1). However, we shall see that these vaccines83
are efficiently targeted at creating protection for the young infants most at risk of hospitalisation if84
they caught RSV.85
The modelling approach used in this paper differs from the majority of RSV modelling ap-86
proaches extant in the literature, which largely focus on deterministic age structured transmission87
models Pitzer et al. (2015); Kinyanjui et al. (2015); Yamin et al. (2016); Hogan et al. (2016). In88
contrast, we explicitly model the social clustering of individuals into households. The advantage89
of explicit inclusion of household structure in the model is that the social contacts within the90
household are persistent over multiple RSV seasons, whereas age-structured models implicitly91
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assume random mixing; that is all people of a given age group are equally likely to be contacted92
by any individual at any instant and therefore the chance of repeated contact become zero as the93
population size becomes large. In the specific case of modelling highly seasonal RSV transmission,94
it is likely that capturing the network-like transmission structure of the population is important95
for representing the relevant epidemiology. Most people have caught RSV by the age of two, and96
will have multiple repeated episodes during their lifetime. The time between recovery from an97
episode and reversion back to at least partial susceptibility is estimated to be 6 months Ohuma98
et al. (2012). In Kilifi county, there are sharp annual peaks of RSV hospitalisation at each seasonal99
RSV epidemic, and so one should expect the population to consist of large numbers of entirely100
susceptible individuals, who have never caught RSV before and are primarily in their first two years101
of life, and partially susceptible individuals, who have caught RSV at least once before, due to the102
inter-epidemic period being longer than the typical time over which loss of immunity to RSV occurs.103
These general considerations suggest that (i) RSV seasonal epidemics will be akin to repeated104
invasions of a nearly susceptible population, i.e. closer to an epidemic scenario than an endemic105
scenario, and (ii) RSV transmission is much closer to a SIS rather than a SIR paradigm. Social network106
effects in epidemiological forecasting are most important during an epidemic invasive growth phase107
and are typically more important for SIS-type dynamics with persistent contactsMiller (2009); Sun108
et al. (2015). Both these features appear to be important for seasonal RSV transmission in Kilifi and109
therefore provide strong motivation for the network-type epidemic model we have used.110
Two possible explanations for the comparative lack of using household structure in RSV mod-111
elling are: first, accounting for the interplay of demography and household structure remains a112
significant modelling challenge Glass et al. (2011); Geard et al. (2015), and second, the dynamics113
of age structured transmission models can be predicted using a comparatively small set of de-114
terministic rate equations Keeling and Rohani (2008). Moreover, whenever natural immunity is115
long-lasting and/or high levels of effective vaccination coverage exist for the population, household116
structure is less important and can be captured using simple approximations e.g. the mother-child117
contact approximation Atkins et al. (2016). As a possible alternative modelling framework stochas-118
tic individual-based models (IBMs) for epidemics benefit from additional realism and flexibility119
compared to deterministic models, and there does exist at least one modelling study considering120
the effect of social structure on RSV transmission using a non-seasonal approximation within a121
stochastic individual-based model (IBM) Poletti et al. (2015). However, rigorous inference of model122
parameters for stochastic IBMs of epidemics is highly challenging because, along with other dif-123
ficulties, the random infection times of each case will not typically be known O’Neill and Roberts124
(1999). The model used in this paper required a rate equation for each possible household con-125
figuration House and Keeling (2008). Specifically for RSV modelling it has been noted that this126
could lead to thousands of rate equations that must be simulated simultaneously Kinyanjui (2014),127
effectively rendering the model impractical for regression against data due to slow integration128
time. Nonetheless, this work demonstrates that by making appropriate simplifications, and using129
numerical solvers adapted to large systems (in this case ∼2000 variables), it was possible to both130
include realistic household structure and rigorously infer model parameters for a model of RSV131
transmission in a LMIC setting.132
Results181
The RSV transmission model parameters were either drawn from the RSV literature or inferred from182
age-stratified weekly hospitalisations at Kilifi county hospital (KCH) between 2002-2016. The underly-183
ing biology of the transmission model was similar to a simple compartmental model of RSV infection184
and waning immunity (see Box 1) with two main differences: (i) the age of the individuals affected185
their susceptibility to RSV, infectiousness after contracting RSV, duration of RSV infectiousness, and186
likelihood of developing severe disease and being hospitalised after contracting RSV, partly because187
of age-specific effects, and partly because we assumed that every person had caught RSV at least188
once after their first year of life, and (ii) infectious contacts were distributed at two-levels of social189
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Box 1. Vaccination predictions from a simple unstructured RSV
epidemic model
133
1345
The essential idea in this paper is to use antenatal contact between mothers-to-be and health
professionals to deploy two separate vaccines: first, a vaccine targeting the mothers-to-be
which boosts the duration of protection her newborn will have against RSV (MAB vaccine), and
second, a vaccine aimed at the mothers-to-be’s household cohabitants giving each a period of
RSV immunity, equivalent to that of a natural infection (IRP vaccine). As a baseline for under-
standing RSV transmission we can use a simple mechanistic model which captures the essential
biology of RSV infection; newborns are born with a period of immunity to RSV infection which
is lost during their first year of life, after contracting RSV the individual is infectious for a period
before gaining temporary waning immunity to RSV re-infection. Assuming homogeneous
transmission the dynamics of the simple RSV transmission model can be described using four
dynamic variables describing the numbers of currently maternally protected individuals (M),
susceptibles (S), infecteds (I) and immune/recovereds (R). The evolution of the epidemic, after
vaccination, can be given as a standard ODE:
푀̇ = 퐵 − 훼푣푎푐푀 − 휇푀, 푆̇ = 훼푣푎푐푀 −
훽
푁
푆퐼 + 휈푅 − 휇푆 − 퐵⟨퐻⟩푉푐표푣 푆푆 + 퐼 + 푅,
퐼̇ = 훽
푁
푆퐼 − 훾퐼 − 휇퐼, 푅̇ = 훾퐼 + 퐵⟨퐻⟩푉푐표푣 푆푁 − 휇푅 − 휈푅.
Where each term above describes the rate of events that change the epidemic state: Births (퐵),
loss of maternally derived protection after MAB vaccination, (훼푣푎푐), mortality (휇), RSV force ofinfection (훽퐼∕푁), recovery (훾), reversion to susceptibility (휈), as standard in the literature An-
derson and May (1992); Keeling and Rohani (2008). The rate at which IRP vaccines successfully
vaccinate susceptibles is 퐵⟨퐻⟩푉푐표푣푆∕(푆 + 퐼 + 푅); that is the mean size of a pregnant woman’shousehold (⟨퐻⟩) times the effective coverage of the vaccine (0 ≤ 푉푐표푣 ≤ 1) time the likelihood ofselecting a susceptible and not wasting the vaccine assuming that we are only targeting those
who have definitely lost their maternal protection to RSV (푆∕(푆 + 퐼 + 푅)). For simplicity, we
can treat the duration of maternal protection as very short compared to the typical person’s
lifetime (i.e. 훼푣푎푐 ≫ 휇). The equilibrium of the simple RSV model is analytically tractable (seeappendix 2):
Relative reduction in transmission due to vaccination = 휇⟨퐻⟩푉푐표푣
(휈 + 휇)(푅0 − 1)
Reduction in transmission per IRP vaccine = 훾 + 휇
푅0(훾 + 휇 + 휈)
Where 푅0 = 훽∕(훾 + 휇) is the reproductive ratio of RSV, and we are assuming that the birth rateis at replacement 퐵 = 휇푁 . The simple RSV model makes some general predictions about the
efficacy of IRP vaccination:
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• The MAB vaccine does not significantly effect transmission in the general population.169
• The efficiency of the IRP vaccine (avoided infections per effective dose) should not change
with coverage.
170
171
• Using parameters typical of the study population at Kilifi (see appendix 2), the reduction
in RSV transmission due to IRP vaccination can be modest because the deployment rate is
too low; for 푅0 = 2 the maximum achievable reduction in transmission is < 4% comparedto no vaccination.
172
173
174
175
Therefore, a naive simple model of RSV transmission is pessimistic about the joint vaccination
strategy. However, in this study we also account for more detailed social structure, differential
susceptibility, infectiousness, and risk of disease dependent on the age of the individual and
seasonality in transmission. We will see that targeting vaccines socially close to young infants
is much more effective than the simple model predicts.
176
177
178
179
180
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mixing differentiating between persistent contacts between household co-occupants and randomly190
assigned contacts within the community of Kilifi county based on the ages of the infected and191
infectee (Fig. 1 and Methods). The joint age and household distribution of the population accessing192
KCH was chosen to match the ongoing findings of the Kilifi Health and Demographic surveillance sys-193
tem (KHDSS; Scott et al. (2012)). The seasonality of RSV hospitalisations at KCH has historically been194
erratic with peak months for RSV hospitalisation varying as widely as November to April (appendix195
1). Moreover, over the 15 year period we are studying in this paper, there was demographic change196
in the underlying population both in age profile and household size distribution. We addressed197
these modelling challenges: first, by rejecting the typical epidemiological modelling assumption that198
population demographic structure is at equilibrium in favour of directly modelling demographic199
change, and second, by treating the shifting seasonality of RSV transmission in Kilifi as being driven200
by an underlying latent random process to be jointly inferred with model parameters. The goal was201
to account for factors influencing the rate of hospitalisations that changed over the 15 years of202
study so as to get an unbiased estimate of parameters we assumed were static over the period,203
such as the person-to-person rate of transmission within a household. We were able to broadly204
capture the year-to-year variation in hospitalisation, and age profile of the hospitalised, with only205
six free parameters (Fig. 2, Methods, and appendix 1). The 2005/2006 RSV year (see appendix 1 for206
RSV year definition) was anomalous in that there were three peaks in RSV hospitalisation separated207
by at least a month: two smaller peaks on 11th Dec 2005 and 24th Mar 2006 around a larger peak208
on 24th Feb 2006. The model was unable to explain this unusual year, other years having solitary209
peaks. Outside of the 2005/2006 RSV year there were 2174 hospitalisations during the period of210
study compared to a model prediction of 2147 hospitalisations ([2057, 2238] 95% prediction interval211
). We were unable to jointly identify the rate of school children contacting other school children with212
the rate of homogeneous contact among all over one year olds, therefore we considered a range213
of within school contact rates, and for each value inferred the other six free model parameters214
and assessed the efficacy of vaccination for a range of MAB vaccine effectiveness values and IRP215
vaccine coverage values. Each scenario gave similar results for the efficacy of household targeted216
vaccination (see appendix 3), therefore we have only presented results in the main Results section217
for the scenario with the highest rate of within school mixing. At KCH all RSV hospitalisations218
occurred in the under five year olds with 84% of hospitalisations occurring in the under one year219
olds (Fig. 2 B). This finding is consistent with the much higher rates of hospitalisation per RSV220
infection for younger infants Kinyanjui et al. (2015). However, the hospitalisation time series has221
to also be understood in the context of dynamic RSV transmission and demographic change in222
the study population. A general trend of increasing hospitalisations between 2002-2009 is at least223
partially explained by a 16% increase in under ones in the population over that period. The rest of224
year-to-year variation in hospitalisation was explained by seasonal epidemic dynamics, themselves225
driven by shifting seasonality (Fig. 2 A; 1).226
We found that, pre-vaccination, school age children suffered on average the highest force of227
infection, that is the per-capita rate of infectious contacts, from outside of the household followed by228
under one year olds (Fig. 3 A). This finding was dependent on assuming that we had a high degree of229
homophily in the social contacts of school-age children (the high within school transmission scenario230
mentioned above). Other scenarios were considered with lower levels of in-group preference for231
school-age children to contact other school-age children; in the alternate scenarios the parameter232
imputation process found slightly higher rates of contacts within the household and homogeneously233
outside of the household but lead to very similar results (appendix 3 ). The infectious contacts234
outside the household were distributed predominantly to individuals within households of size 2-5235
(Fig. 3). This reflected the household distribution of the population; school children and under ones236
who were most at risk of making social contact with those infected with RSV outside the household237
tended to live in households of this size (Fig. 3 B).238
Force of infection is a less natural concept for measuring within household infection due to small239
numbers of individuals per household, and intense frequent contacts. Instead, we measured the240
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Figure 1. Schematic plot for the RSV transmission model and vaccination programme. Infectious individuals(red character figures) transmit to other individuals inhabiting the same house, and to other individuals in otherhouseholds based on the ages of the both the infector and infectee. Red and blue arrows represent possiblerealised infections over a short period of time. Bottom right household demonstrates the vaccination strategy;the mother has received a maternal antibody boosting (MAB) vaccine which increased transfer of protectiveantibodies to newborns (green background shading), meanwhile other household members have received animmune response provoking (IRP) vaccine (blue background shading).
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Figure 2. RSV hospitalisation at KCH: dynamics and age profile of hospitalised patients. A: Weekly RSVhospitalisations before implementation of vaccinations. Black curve gives mean prediction of RSV householdtransmission model after regression against weekly incidence data (red dots). Grey shaded area indicates the99% prediction interval for the model. Also shown is the number of under ones in the population (dashed line).B: Age profile of hospitalisations at KCH before vaccination. Error bars give 99% prediction intervals for model.
Figure 2–source data 1. Hospitalisation data, and model predictions, are given as MATLAB data files along with
script for plotting figure.
true rate of RSV transmission between individuals cohabiting a household. The highest per-capita241
rates of infection within households were for 7 year olds (Fig. 3 C); this reflected the typical age of242
individuals within the households most at risk of RSV introduction and with severest transmission243
rates after introduction. The infection rate among under ones increased rapidly until it plateaued244
at ∼6 months old. The rapid increase in per-capita infection rate was due to waning of maternally245
acquired immunity to RSV, which we inferred as lasting on average 21.6 days ([17.2, 26.1] 95% CI;246
see table 3 for all inferred parameters). The total infection rate within households was greatest247
in size 5 and 6 households (Fig. 3 D). This differed from the household size where each person248
was at most risk of contracting RSV outside the household. Two factors shifted the burden of RSV249
infection to larger households: first, there are more people in larger households therefore risk of250
RSV introduction can be higher even if the per-person rate is lower, and second, the intensity of251
transmission within households is higher for larger households.252
We evaluated a series of scenarios where a combination of a maternal antibody boosting (MAB)253
and an immune response provoking (IRP), vaccine were targeted at, respectively, mothers-to-be254
in their third trimester, and their household cohabitants upon the birth of the newborn. Between255
scenarios we varied (i) the effectiveness of the MAB vaccine, (ii) the coverage of the MAB vaccine,256
and (iii) the household coverage of the IRP vaccine, see table 1 for a list of all vaccination scenarios257
modelled in this paper. The protective effect of the vaccines on individuals was the same as for258
the unstructured population model presented in Box 1: the MAB vaccine increased the period over259
which a newborn was protected from RSV by maternally acquired antibodies, and the IRP vaccine,260
given to all household cohabitants of some participating mothers-to-be, initiated an immune261
response in the vaccinated which gave a period of protection from acquiring RSV similar to that262
following a natural infection. The high antenatal contact levels in Kilifi county suggested that263
vaccination coverage of mothers-to-be had the potential to be very high, especially if maternal264
immunisation to boost newborn immunity became an established method for a range of vaccines265
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Figure 3. Mean force of infection (2002-2016) between households and mean infection rates within households.A: The mean force of infection (infectious contacts received per person per day) of RSV due to transmissionfrom without the household on three age groups: under-ones, school age children and everyone else, includingadults. B:Mean force of infection due to transmission without the household on individuals inhabiting eachhousehold size. C: The mean per-capita daily rate at which different age groups become infected with RSV fromwithin their household. D: The mean total daily rate of RSV infection within households of different sizes.
Figure 3–source data 1. The model predictions are given as MATLAB data files, along with the script for plotting
figure.
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including influenza and Group B Streptococcus. However, an available MAB vaccine might only be266
effective if delivered in the third trimester of pregnancy and, whilst having at least one antenatal267
contact is very common for pregnant women in Kilifi county, it is not clear that antenatal contact268
always occurs at the relevant stage of pregnancy. Therefore, we consider both an optimistic scenario269
(100% MAB coverage), and a more conservative uptake (50% MAB coverage). The number of days of270
additional maternally derived protection donated to the newborns by MAB vaccinated mothers was271
uncertain, we considered a range of MAB protection 0 - 90 days. We assumed that if the pregnant272
mother’s household cohabitants agreed to receive an immune response provoking vaccine then273
all were vaccinated at the birth of the newborn to maximise the overlap between the protection274
period of the cohabitants and the first months of life of the newborn. As is common in vaccine275
strategy analysis we combine coverage and effectiveness into one effective coverage (coverage276
times effectiveness c.f. Keeling and Rohani (2008)), although in this case effective coverage could277
be considered both within and between households.278
We assumed that the maximum coverage of the vaccine would be reached within a year,279
and considered ten years of RSV transmission after this implementation. When inferring model280
parameters we took care to account for the known changes in demography over the study period,281
both in the age and the household occupancy distributions of the population. However, for the282
10-year forecasting in this paper we assumed that the total birth rate was constant (8,601 per283
year), and that the population age and household occupancy distributions remained static. The284
model inference stage included inferring the statistics of yearly variation in RSV seasonality. The285
decrease in rates of RSV hospitalisation and infection due to vaccination over ten years presented286
are median improvements over 500 independent realisations of random future seasonal patterns287
compared to a baseline of no intervention. If the MAB vaccine was unavailable or ineffective (0288
days MAB protection), we found that it was still possible to reduce RSV hospitalisations by up289
to 25% using only the IRP vaccine on the household members of young infants at time of birth290
(Fig. 4 A and B). If 100% maternal vaccination could be achieved then the MAB vaccine was more291
successful as a sole vaccine option compared to IRP vaccination; in the sense that 90 days of292
additional protection from RSV delivered a 45% reduction in hospitalisation even with no IRP vaccine293
coverage. Nonetheless, even with an effective MAB vaccine there was added benefit to also using a294
IRP vaccine; a greater than 50% reduction in hospitalisations was achieved with a MAB vaccine that295
gave 75 additional days of RSV protection and a 75% coverage of the pregnant womens’ households296
(Fig. 4 A; a colorblind-friendly version of this plot can be found as appendix 4 Fig 2)). If only 50%297
maternal vaccination coverage could be achieved then unsurprisingly also using the IRP vaccine298
became relatively more important. The mixed vaccination strategy that achieved better than 50%299
hospitalisation reduction with 100% maternal coverage achieved 38% reduction in hospitalisations300
with 50% maternal coverage (Fig. 4 B); halving the maternal coverage didn’t necessarily halve the301
success of the vaccination programme so long as IRP vaccine was also available. Improving the302
effectiveness of the MAB vaccine caused a significant improvement in hospitalisations, but had an303
almost negligible effect on the total infections in the population (Fig. 4 C and D). IRP vaccination304
was more effective at reducing total RSV infections, but even at 75% coverage of the households of305
women giving birth the reduction in infections was < 4% (Fig. 4 C and D). That IRP vaccination had a306
modest effect on the true infection rate, and that MAB vaccination has a negligible effect on the307
true infection rate, was in line with the prediction of the simple non-seasonal RSV model (Box 1).308
However, the simple model cannot predict that the percentage reduction in hospitalisations would309
be significantly greater than for total infections because of the direct and indirect protection of those310
most at risk of disease. For the mixed strategy achieving a 50% reduction in RSV hospitalisations311
described above (75 days direct MAB protection at 100% MAB coverage with 75% IRP household312
coverage) the seasonal dynamics of hospitalisations post-vaccination equilibrated rapidly (Fig. 5313
A). There was a reduction in median hospitalisations in every age group, but predominantly in 0-3314
month years old (who are nearly all protected by the MAB vaccine) and 3-6 month year olds (Fig.315
5 B). However, targeting pregnant women and their cohabitants did not prevent sufficient RSV316
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Figure 4. Median forecast effectiveness of RSV vaccination for different mixed strategies over a 10 year periodfor 100% maternal vaccine effective coverage (A and C) and 50% maternal vaccine effective coverage (B and D).A and B:Median percentage reduction in hospitalisations at KCH. C and D: Percentage reduction in total RSVinfections in the population.
Figure 4–source data 1. Reductions in hospitalisations and infections for each of the 500 forecasting simula-
tions are given as MATLAB data files, along with script for plotting figure.
infections as to significantly disrupt RSV transmission within the population at large, which may317
explain the rapid approach to new RSV hospitalisation dynamics. Nonetheless, those who were318
protected were overwhelmingly among those at most risk of disease if they had caught RSV.319
Each vaccine used decreased the expected number of RSV infections and hospitalisations. As320
well as measuring the overall effectiveness of RSV vaccination (see above), we also measured the321
efficiency of vaccination, defined as number of infections or hospitalisations averted per vaccine (of322
either type). Unsurprisingly, as the duration of protection given by the MAB vaccine increased the323
efficiency of vaccination also increased; significantly for hospitalisations (Fig. 6 A) and marginally324
for infections (Fig. 6 B). This was true whether an IRP vaccine was used, or not. If there is no MAB325
vaccine available, then the efficiency of using only IRP vaccination doesn’t change with coverage;326
that is that when increasing IRP household coverage the improvement per vaccine used stayed327
static, in line with what one might expect from a homogeneous mixing RSV model (see box 1).328
However, when MAB and IRP vaccines were used in conjunction there was an efficiency penalty due329
to redundancy in the each vaccine’s protective effect. For example, if a MAB vaccine was available330
that gave 90 days protection the marginal benefit in terms of decreased hospitalisations of having331
an IRP vaccine was decreased because most at-risk infants were already protected by the MAB332
vaccine (Fig. 6 A). Using two types of vaccine always decreased infections and hospitalisations (see333
above), but the total reduction was always less than simply adding the reductions of each vaccine in334
the absence of the other.335
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Figure 5. 10 year forecast of RSV vaccination effectiveness for a mixed strategy of an MAB vaccine provided 75days of additional RSV protection for newborns and a 75% IRP vaccine household coverage. A: Forecast weeklyhospitalisations for a baseline of no vaccination (blue) and the mixed vaccination strategy (red). Shown aremedian forecast (curves) and 95% prediction intervals (background shading). B: Forecast age distribution of totalRSV hospitalisations at KCH. Median forecast (bars) and 95% prediction intervals (error bars).
Figure 5–source data 1. Hospitalisation predictions for each of 500 forecasting simulations is given as a
MATLAB data file, along with a MATLAB function for combining the forecasting and Poisson hospitalisation rate
uncertainties into a prediction interval and plotting script.
Figure 6. Forecast vaccination efficiency against hospitalisations and all infections, defined as number of casesaverted per vaccine used (both MAB and IRP). MAB vaccine coverage was 100% unless unavailable, howeverMAB protection duration varied (different coloured bars) and IRP household coverage was also varied. See table1 for a list of scenario. A:Median avoided hospitalisations at KCH per vaccine over 500 simulations. B:Medianavoided RSV infections in population per vaccine over 500 simulations.
Figure 6–source data 1. A MATLAB script for converting 500 forecasting simulation outcomes into efficiency
metrics, and plotting them.
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Table 1. Modelled vaccination scenarios. Each combination of MAB vaccine effectiveness and coverage, withIRP vaccine coverage below was one scenario. The baseline scenario being no effective MAB vaccine and 0%coverage of IRP vaccine.
Description Range
Additional period of protection from RSV at birth due to mater-nal antibody boosting (MAB) vaccine (푃 ). 0 (no vaccine), 15, 30, 45, 60, 75, 90 daysCoverage of mothers with MAB vaccine 50%, 100%Coverage of households with newborns with immune responseprovoking (IRP) vaccination (푉푐표푣)
0%, 25%, 50%, 75%, 100%
Discussion336
Our modelling analysis suggested that a high coverage vaccination campaign of mothers-to-be337
with a vaccine inducing elevated levels of transplacenta RSV antibody transfer to her newborn,338
alongside targeting the newborn’s cohabitants with a generic vaccine that provoked a period of339
immunity to RSV can achieve greater than 50% reduction in hospitalisations due to RSV. This340
combined vaccination strategy suggested itself due to the high antenatal contact rates between341
mothers-to-be and health professionals in Kilifi county, Kenya (97.5% KNBS (2015)). We found that342
the combined vaccination strategy was efficient at targeting effort towards directly protecting343
young infants most at risk of developing RSV disease with boosted antibodies, and filling in any gap344
in protection with indirect cocoon protection within the household using a vaccine aimed at older345
cohabitants. Even at maximum effective household coverage for the IRP vaccination only ∼10% of346
the population were vaccinated each year with a modest reduction in the RSV infection rate of ∼5%.347
Nonetheless, at that coverage IRP vaccination alone achieved a 25% reduction in hospitalisations348
at KCH even without an effective MAB vaccine to provide direct protection to young infants. This349
demonstrated that although we were vaccinating at a low rate compared to population size, with350
only a modest reduction in infection rate, those people we did vaccinate were efficient at cocooning351
young infants from transmission and therefore risk of severe disease. If an effective MAB vaccine352
was also available the reduction in hospitalisations was greater, although the additional protection353
due to cocooning was relatively less since young infants were also protected from contracting RSV354
at the age when they were at most risk of severe disease.355
We constructed the model used in this paper with the purpose of estimating the efficacy of356
targeting pregnant women and their households for vaccination. In order to make predictions357
mechanistic models of disease transmission must approximate the social structure of the popula-358
tion being modelled, and hence the contact rates between individuals. The focus on household359
transmission in this paper necessitated including households into the modelled social structure;360
this represented significant additional effort in model construction, computational resource and361
inference compared to simpler models. A more common approach in the literature is to treat362
the contact rates between individuals as being determined only by their respective ages. This363
approach has the benefit of being conceptually straight-forward and draws on a number of recent364
and high-quality studies which quantify social contact patterns by age stratificationMossong et al.365
(2008); Kiti et al. (2014); Prem et al. (2017). However, the fundamental theory of age-structured366
transmission models for endemic diseases was developed mainly with reference to diseases that367
induce very long term or lifelong immunity Anderson and May (1992). For diseases provoking long368
lasting immunity one would expect most older household members to be immune and there-369
fore household structure to be a relatively less important factor in predicting risk of transmission370
compared to the age-structured transmission outside of the household. Indeed, simulation study371
of a generic strongly immunizing infection with realistic demography found limited difference372
in predicted incidence rate by age for people at schooling age or older between models with373
household structure and age structure compared to models with only age structure Geard et al.374
(2015). However, it is not clear that neglecting household structure is a good approximation for375
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modelling seasonal RSV transmission for two reasons: first, previously infected people lose effective376
immunological protection to RSV rapidly enough that each season could be closer to an ’epidemic’377
scenario rather than an ’endemic’ scenario. Second, every hospital admission at KCH confirmed as378
due to RSV was a pre-school aged child; in contrast to predicted incidence rates for school age and379
older individual, the simulation study cited above Geard et al. (2015) predicted that incidence was380
lower for 0-5 year olds, especially so for under one year olds, once household structure was taken381
into account. It would be of great interest to have a more general theoretical understanding of382
which epidemiological questions require household structure, or a more general meta-population383
structure, for epidemiological modelling, and which don’t. This remains an active area of research384
Ball et al. (2015).385
A cocooning protective effect of households could explain the big discrepancy between our386
estimate of the mean period of protection against RSV after birth due to transplacental transfer387
of antibodies from mother to baby in the the womb (21.6 days of natural protection on average)388
compared to a RSV transmission modelling study by Kinyanjui et al on the same population using389
an age-structured model Kinyanjui et al. (2015) (2.3 months of natural protection if the age mixing390
was based on diary estimates of contacts Kiti et al. (2014) or 4 months of natural protection if391
the age mixing was based on household co-occupancy and schooling ages). The age-structured392
model used in the Kinyanjui et al study reported high or very high reproductive ratios: 7.08 for the393
diary based contact patterns, and 25.60 for the household co-occupancy and schooling age based394
contact pattern. Therefore, to fit the KCH hospitalisation data the age structured model necessarily395
predicted a very high level of natural protection due to maternal antibodies to compensate for the396
predicted high force of infection on young infants. In our model we included household structure397
and we fit to the same KCH data but with a much lower level of natural protection from RSV. This398
in turn changes the guidance modelling gives to vaccination strategy; some age structured RSV399
transmission models have emphasized reducing force of infection by vaccinating infants directly400
Kinyanjui et al. (2015), and find that maternal vaccination is likely to be of limited impact Pan-Ngum401
et al. (2017), because they have inferred that the RSV reproductive ratio is high and, therefore,402
natural protection to RSV is also inferred to be high. In contrast, we infer that natural protection to403
RSV is low and therefore find that maternal vaccination in combination with elevating the cocoon404
protection to young infants provided by vaccinating household co-inhabitants is a highly efficient405
strategy. Another age-structured RSV transmission model Yamin et al. (2016) has found that406
vaccinating under-fives to RSV along with their influenza vaccination was highly efficient because of407
the large number of secondary cases generated per infected under-five year old. Again, it is not408
clear whether this result extends to a population structured into households where it is known409
that clustering in contacts has a complex interplay with disease dynamics, either reducing spread410
because infectious contacts are ‘trapped’ in the local cluster (e.g. the household) or promoting411
spread by enhancing persistenceMiller (2009); Sun et al. (2015).412
This was a modelling study and, as ever, there are factors that we have neglected in our analysis413
that could be addressed in future work. First, we treated coverage of the maternal vaccine and the414
IRP vaccine as independent. In reality, the simplest and cheapest scenario whereby the household415
cohabitants of pregnant mothers are recruited to the vaccination programme is if they attend416
antenatal contact with the mother-to-be. The percentage of pregnant women for have at least one417
antenatal contact in Kilifi county is high (97.5%; KNBS (2015)), however it is not clear that antenatal418
contact always occurs in the mother-to-be’s third trimester. Both the MAB and IRP vaccines are419
likely to be best deployed late in the pregnancy, in order to maximise direct protection from the420
MAB vaccine and the duration of indirect protection from the IRP vaccine for the newborn. This421
means that if the only antenatal contact with the mother-to-be is relatively early in her pregnancy422
then both the MAB and IRP vaccines might fail; that is the households outside of MAB coverage are423
also likely to be those outside of IRP coverage violating our independent deployment assumption.424
Our results suggest that a MAB vaccine at a high coverage sharply reduces RSV hospitalisation even425
when the amount of additional protection is low (15 days) and if the MAB vaccination coverage426
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is reduced to 50% IRP coverage becomes relatively more important to reducing hospitalisations.427
To avoid having many household unprotected by both MAB and IRP vaccination, it could be cost428
effective to devote extra resources towards encouraging pregnant women, and their cohabitants,429
who present early in the pregnancy to return for vaccination later in the pregnancy. Second, the430
cost per vaccine remains unknown and we have not considered any measurement of the burden of431
disease other than hospitalisations at KCH. RSV hospitalisations have been identified as a crude432
proxy for the true disease burden; the passive reporting of RSV hospitalisation can vary for reasons433
completely independent of RSV epidemiology Modjarrad et al. (2016). Third, despite accounting434
for demographic change in our inference of model parameters we neglect demographic change in435
our forecasting , concentrating instead on predicting the reduction in hospitalisations compared436
to a baseline of a static population without intervention. Including demographic change in our437
parameter inference step allowed us to disentangle seasonal variation in hospitalisation from438
simply changing numbers of at-risk children. The demography in Kilifi will continue to change in439
the future, the crude birth rate in Kilifi has followed a declining trend in line with the rest of Kenya.440
However, this leads to a total birth rate which is much closer to static (∼ 8,500 births per year), and441
therefore the number of at-risk under-ones has been approximately static since 2009. We avoided442
exploring complications such as the effect increased crowding within households might have on443
the risk per-newborn in this paper by assuming that the rest of the population was also static over444
the 10 years of forecasting. Further exploring more detailed issues around shifting patterns of445
household cohabitancy would be an interesting avenue to explore in future work. Our primary goal446
in this paper has been to establish the importance of thinking jointly about hospitalisation risk,447
population structure (in particular household co-occupancy) and future vaccination programmes.448
We have demonstrated that, all other things be equal, combining partially effective vaccines can be449
complementary in a household-structured setting. These issues would suggest that RSV vaccination450
policy would benefit from further cost-benefit analyses tailored to LMIC settings, possibly using451
more flexible stochastic IBMs with the model parameters inferred in this study.452
In conclusion, in this paper we have analysed the performance of a joint maternal and household453
targeting RSV vaccination strategy measuring both reduction in hospitalisations and the true454
population incidence rate. We drew our conclusions based on rigorous inference of underlying455
transmission parameters and the inherent protection to RSV newborns received from their mothers,456
taking into account potential confusing factors such as variable seasonality and demography. Two457
central insights from our study were that the duration of natural protection to RSV that newborns458
inherit from their mother was likely to be much shorter than previously estimated and that RSV459
attack rates within the household were significant in maintaining RSV transmission. Therefore,460
targeting pregnant women and their households for RSV vaccination is likely to be an effective and461
efficient strategy under a wide range of different scenarios.462
Methods463
The dynamical RSV model used in this paper simulated infection and transmission of RSV among464
a population described by the Kilifi Demographic and Health surveillance system (KHDSS Scott465
et al. (2012)) between September 2001 to September 2016. The population was assumed to466
mix and transmit RSV at two social levels: within their household and outside their household467
among the wider community. RSV infection was modelled using a modified version of the classic468
susceptible, infected, recovered (SIR) compartmental framework Anderson and May (1992); Keeling469
and Rohani (2008). The main modifications were consistent with previous RSV transmission models;470
we assumed that: (i) individuals were born with a temporary immunity to RSV which faded over471
time, and (ii) RSV infection episodes provide individuals with only temporary protection from re-472
infection (mean 6 months Scott et al. (2006)) White et al. (2007); Moore et al. (2014); Pitzer et al.473
(2015); Kinyanjui et al. (2015); Yamin et al. (2016). The high dimensionality of the ODE model (see474
below) used in this paper necessitated a relatively simple compartmental structure for RSV infection475
progression, therefore the population is only crudely age stratified into under-one year olds (U1s)476
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and over-one year olds (O1s). However, more detailed information about the age of the individuals477
in the model was available by considering their age distributions conditional on their crude age478
category and the type of household they inhabited (see below). After an initial RSV infection there479
is evidence that individuals retain reduced susceptibility to subsequent RSV infection Henderson480
et al. (1979); Hall et al. (1991), and will potentially have less infectious asymptomatic episodes if481
infected Hall et al. (2001); Yamin et al. (2016). Some RSV transmission models, using simpler social482
structures, therefore allow individuals to be characterised by both their age and their number of483
previous RSV infections Kinyanjui et al. (2015); Yamin et al. (2016). In the model used in this paper484
we assumed that all U1 individuals susceptible to RSV were at risk of their first RSV episode and485
that all O1 individuals had already been infected at least once, since re-infection within the same486
yearly epidemic is unlikely but nearly everyone has caught RSV by the age of two years old Glezen487
et al. (1986).488
Joint distributions of age and household occupancy489
As mentioned above, the high dimensionality of the RSV transmission model with two levels of social490
mixing was a limiting factor on the possible complexity of the compartmental framework represent-491
ing the possible combinations of age and disease state (see appendix 2). In order to both capture492
the structure of the population in households and incorporate finer-grained information about the493
ages of the modelled individuals we calculated empirical joint distributions for the proportion of494
individuals of different ages in various household sizes, and whether that household contained495
an under-one year old. We did not restrict the age categories of this joint age-and-household496
distribution to just under-one or over-one, instead preferring finer-grained age categories: (i) each497
month of first year of life, (ii) each year of life aged 1 - 18 and (iii) 18+ years old. We used the498
Kilifi health and demographic surveillance system (KHDSS; Scott et al. (2012)) to construct the joint499
distributions, which records for each individual a unique person ID, a birth date, immigration into500
the KDHSS date(s), out-migration from the KHDSS date(s), and a unique building ID for where they501
live during their time in the KHDSS. By combining this data we could calculate,502
ℙ푡(푎, 푛, 푈 ) =
푁푡(푎, 푛, 푈 )
푁푡
. (1)
Where 푁푡(푎, 푛, 푈 ) was the number of individuals on day 푡 who were jointly in age category 푎, lived503 in a household of size 푛, which either contained at least one under one year old (푈 = 1) or not504
(푈 = 0), and 푁푡 was the total population size on day 푡. The joint distribution changed over time, we505 calculated ℙ푡(푎, 푛, 푈 ) for a series of year-start days 푡 = 1st Jan 2000, 2001,..., 2016. We then used ℙ푡506 as representative for the rest of the year. Because the exact birth dates where missing for a large507
number of people, and for model simplicity, we assumed that all U1 individuals aged to become O1508
individuals at a constant rate 1 per year, which was equivalent to assuming that given that the exact509
age of an U1 individual was uniformly distributed between 0 and 1 years old, independently of the510
U1’s household configuration.511
Conditional age of individuals512
The dynamic model of transmission tracks whether individuals are under-one or over-one years513
old, however for estimating the risk of disease per infection it was useful to use the conditional age514
distribution for the finer-grained age category of an individual based on her dynamic model age515
category 푎 < 1 year or 푎 > 1 year, her household size and whether the household contained an U1516
or not, for example,517
ℙ푡(푎|푛, 푈, 푎 > 1 year) = ퟏ(푎 > 1 year)ℙ푡(푎, 푛, 푈 )∑
푏>1 year ℙ푡(푏, 푛, 푈 )
. (2)
The conditional distributions for an individual’s household size and whether they lived in a house-518
hold containing an U1 based on their age were constructed similarly. The reason we included a519
variable indicating whether the household of the individual contained an under one or not was520
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because it was important to capture the pathway to transmission to the under-one year olds most521
at risk of disease due to contracting RSV.522
Model Dynamics, forces of infection and susceptibility to RSV523
The fundamental unit of the RSV transmission model developed for this paper was the household.524
Each household was described by the number of each type of individual inhabiting it, which we call525
the household configuration. The type of individual within each household was identified by her RSV526
disease state and age category. The RSV transmission model described the dynamics of the number527
of households that were in each possible household configuration using an approach introduced528
by House and Keeling (House and Keeling (2008)). Mathematically, the number of households in529
a given household configuration at time 푡 was denoted퐻푠1 ,푖1 ,푟1 ,푠2 ,푖2 ,푟2 (푡), referring to the household530 configuration with exactly 푠1 U1 susceptibles, 푖1 U1 infecteds, 푟1 U1 recovered, 푠2 O1 susceptibles,531
푖2 O1 infecteds, and 푟2 O1 recovereds. In order to limit the number of possible household states532 we included only households of total size ten or less with two or fewer under ones. We chose533
these limits on the household size based on capturing ≈ 99% of the U1s in the population, and534
therefore the pathway to them catching RSV (appendix 2). There were 1926 possible household535
configurations in the RSV transmission model. The vector푯(푡) of number of households in each536
possible household configuration evolved according to the semi-linear ODE:537
푯̇(푡) = 퐴푡푯(푡) + 풇푡(푯(푡)) + 흆푡(푯(푡)). (3)
Each term describing the vector field of equation (51) corresponded to a dynamic component of538
the model:539
1. RSV transmission within households, recovery of infected individuals, loss of immunity of540
recovered individuals, aging from U1 to O1 and turnover in household occupancy due to541
births and individuals leaving the household (퐴푡푯(푡)).542 2. RSV transmission between households due to age-group specific mixing (풇푡(푯(푡))).543 3. Change in household numbers due to population flux, (흆푡(푯(푡))).544
See appendix 2 for further details. The force of infection due to transmission within a household545
of generic configuration (푠1, 푖1, 푟1, 푠2, 푖2, 푟2) was density dependent; that is the person-to-person546 infection rate in the household did not depend on household size,547
휆ℎℎ = 휏훽(푡)(푖1 + 휄2푖2). (4)
Where 휏 is the basic within-household transmission rate, 휄2 is the relative decrease in infectiousness548 of O1s compared to U1s, and 훽(푡) is the seasonal variation in the transmission rate of RSV (see549
appendix 1). Transmission outside of the household within the wider community was assumed to550
be based on the finer-grained age categories introduced above. The conditional age distributions551
of the individuals allowed us to construct matrices (푃퐻→퐴,푡) to convert between the household552 configuration vector into a vector of number of infected individuals in each age category, weighted553
by their relative infectiousness, for any time 푡 during the simulation: 푰(푡) = 푃퐻→퐴,푡푯(푡) (appendix 2).554 The force of infection on each individual due to age-based mixing in the community was,555
흀푎푔푒 = 훽(푡)푇 푰(푡)∕푁(푡). (5)
Where 푇 was the community infection rate matrix and 푁(푡) was the total population size at time556
푡. In this formulation, the rate at which an infected in age group 푏 creates infectious contacts557
in the community with individuals of age group 푎 is 푇푎푏푁(푎, 푡)∕푁(푡) where 푁(푎, 푡) is the number558 of individuals in age group 푎 at time 푡 Keeling and Rohani (2008). The force of infection on an559
individual within a given household was calculated using matrices constructed from the conditional560
distribution of an individual’s household type given her age, 휆푐표푚 = 푃퐴→퐻,푡흀푎푔푒. The total force of561 infection on each individual was the sum of her infectious contact rates within the household and562
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within the community, 휆 = 휆ℎℎ + 휆푐표푚 + 휆푒푥푡. Where 휆푒푥푡 = 휖훽(푡)∕푁(푡) was the force of infection from563 outside KHDSS.564
The actual infection rate for each individual was the force of infection ‘felt’ by the individual565
times the susceptibility of the individual. The susceptibility of under one year olds (휎푈1) depended566 on whether or not the U1 individual was still protected from RSV by maternally acquired antibodies,567
which we modelled as giving a random 푀 days of protection; that is for an individual of age 퐴568
days, 휎푈1 = 0 if 푀 > 퐴 and 휎푈1 = 1 otherwise. In general, the infection status of an individual569 correlates with her age. However, because RSV is strongly seasonal we do not treat the age of570
an U1 as correlated with her susceptibility arguing that every U1 is facing her first RSV season571
irrespective of whether she is one month old or 11 months old. Therefore, the mean susceptibility572
for under-ones was 휎푈1 = ℙ(푀 ≤ 퐴). The susceptibility of over one year olds was chosen as if573 the individual had definitely received at least one RSV infection in the past, and definitely had no574
chance of being maternally protected. We modelled the duration of maternal protection푀 as a575
truncated exponential distribution conditioned on being less than one year in duration; that is576
푀 ∼ exp(훼)|(푀 ≤ 1 year) (appendix 2).577
Hospitalisation rates578
The chance of an infected individual becoming severely diseased after contracting RSV, and then579
seeking care at hospital, depended on that person’s age and number of infections Nokes et al.580
(2008); Ohuma et al. (2012). When an U1 was infected in the model her age at infection was given581
by conditioning on the age of the U1 being greater than her maternal protection period,582
ℙ(퐴 ∈ 푎|푀 ≤ 퐴). (6)
Which was calculated exactly (see appendices 2 and 4). This took into account that increasing the583
duration of maternal protection would increase the age at infection and therefore reduce the risk584
of disease. O1s were assumed to have no maternal protection but their conditional age depended585
on their household type [equation (2)]. We used these conditional distributions to convert the586
incidence rate of U1s and O1s in each household type into dynamic incidence rates in each age587
category, 푎(푡). By assuming that all O1s had been infected at least once we could use previously588 published age-dependent hospitalisation odds per infection ℎ푎 (Kinyanjui et al. (2015) and appendix589 3) to determine the cumulative hospitalisations predicted by the model for each age category 푎 and590
week interval 푤푖 = (푡푖,1, 푡푖,2),591
(푎,푤푖) = ∫
푡푖,2
푡푖,1
푎(푡)ℎ푎d푡. (7)
Parameter Inference592
The majority of the parameters for the RSV transmission model were drawn from the RSV literature593
(see table 2 and appendix 3) leaving four parameters, and the five hyperparameters of a normal594
distribution describing the random yearly variation in log-seasonality, to be inferred from hospitali-595
sation data (see table 3 for parameter estimates and appendix 1 for further details on seasonality596
model). The free parameters and distribution of the RSV transmission model were:597
• Community infection rate outside the household between U1s and all others in the community598
accessing KCH (푏푈1).599 • Community infection rate outside the household among all O1s in community (푏푂1).600 • Infectious contact rate within the household to all other household members (휏).601
• Mean duration of maternally derived immunity to RSV (푀 ).602
• The joint normal distribution of the yearly log-seasonality amplitude and phase ([휉, 휙] ∼603
 (흁,횺)).604
We also included an infectious contact rate for children of schooling age (5-18 years old; 푏푆 ) which605 acted additionally to 푏푂1; that is children of schooling age were at additional risk of contracting RSV606
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Table 2. Parameters from literature and chosen for model.
Parameter Description Value Data source
휎푂1 Susceptibility (O1s) 0.75 Henderson et al. (1979)
휄2 relative infectiousness (O1s) 0.5 Kinyanjui et al. (2015)
휈 Rate of waning of immunity 2 per year Agoti et al. (2012)
훾1 Rate of recovery for under-ones 1/9 per day Hall et al. (1976)
훾2 Rate of recovery for over-ones 1/4 per day Hall et al. (1976)
푏푆 Community transmission rate atschools 0,1/3,2/3,1 per day range
휂 Ageing rate for U1s 1 per year model choice
휖 Base external infection rate (whole pop-ulation) 10 per day model choice
on top of the risk due to mixing in the community. This meant that the mixing matrix in equation607
(5) was in block form,608
푇 =
⎛⎜⎜⎜⎝
푏푈1 푏푈1 푏푈1
푏푈1 푏푆 + 푏푂1 푏푂1
푏푈1 푏푂1 푏푂1
⎞⎟⎟⎟⎠ . (8)
Where the blocks represented respectively under-one age categories, over-ones at school age609
categories and over-ones above school age categories. Unfortunately, we were unable to reliably610
identify 푏푆 parameter jointly with the other parameters. Investigating a range of 푏푆 values gave611 similar results for model fit and predictions for vaccine efficacy, the results in the main paper612
were for the highest value of 푏푆 considered which was mildly pessimistic compared to 푏푆 = 0 (see613 appendix 3).614
The data for parameter inference was RSV-confirmed, age-specific weekly admissions to Kilifi615
county hospital (KCH) hospitalisation data from September 2001 until September 2016 (see Nokes616
et al. (2009) for study details). KCH serves as the primary care facility for the KHDSS population, and617
we assumed that all KHDSS members who accessed urgent hospital treatment due to RSV disease618
accessed their treatment at KCH. However, a significant number of admissions were from people619
not within the KHDSS survey leading to data re-scaling (see appendix 3). The log-likelihood for a620
particular simulation corresponded to Poisson errors,621
ln =∑
푖
∑
푎
ln 푓푝표푖(푖,푎|(푎,푤푖)). (9)
Where 푖,푎 was the cumulative number of hospitalisation observed at KCH in age category 푎 on622 week 푤푖 and 푓푝표푖(푥|휇) is the probability mass function for a Poisson distribution with mean 휇.623 If the yearly realisations of the random seasonality (see appendix 1) were known, then the entire624
model would be deterministic and ln would be a function of the unknown parameters. Therefore,625
we treated the yearly variation in seasonality asmissing data and used the Expectation-maximisation626
(EM) algorithm Dempster et al. (1977) to converge onto maximum likelihood estimates for the627
four free parameters, and the two hyperparameters of the log-seasonality model, 95% confidence628
intervals were constructed using the likelihood profile technique (e.g. King et al. (2008) and appendix629
3).630
Modelling Vaccination631
There were two vaccines used in this modelling study, which were deployed as part of the antenatal632
contact between pregnant women and skilled health professionals. We assumed that the maternal633
vaccine was delivered as one injection to the pregnant women in her third trimester. This achieved634
some unknown additional period of maternal protection, 푃 days, on top of the random period635
푀 , that is after maternally vaccinating the period of protection became푀푣푎푐 =푀 + 푃 . Achieving636 an effective maternal vaccination coverage of 푉푐표푣 shifted the mean susceptibility of U1s to 휎푈1 =637
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Table 3. Inferred Parameters.
Parameter Description Value
푏푈1 Community transmission rate for U1s 0.22 [0.18,0.27] per day
푏푂1 Community transmission rate for O1s 0.20 [0.18,0.21] per day
휏 Transmission rate to each other member of household 0.040 [0.032, 0.048] per day
푀 Mean duration of maternal protection at birth 21.6 [17.2, 26.1] days
푚휉 Mean amplitude of log-seasonality 0.61 [0.51, 0.72]
푚휙 Mean timing of log-seasonality peak (phase) 67.7 [40.2, 77.7] days
휎휉 Std. amplitude of log-seasonality 0.20 [0.098,0.31]
휎휙 Std. timing of log-seasonality peak (phase) 38.7 [30.0, 48.5] days
휌휉휙 Corr. coefficient between log-seasonal amplitude and phase -0.035 [-0.12, 0.072]
ℙ(푀푣푎푐 < 퐴)푉푐표푣 + ℙ(푀 < 퐴)(1 − 푉푐표푣), a linear increase in 푉푐표푣. The change in distribution of age at638 infection was non-linear in 푉푐표푣 because, conditional on an U1 being infected, it was more likely that639 the U1’s mother had not been vaccinated than the unconditional probability of non-vaccination,640
1 − 푉푐표푣 (see appendix 4). We also assumed that there was a vaccine available that provoked an641 immune response in the vaccinated individuals similar to a natural infection; that is a susceptible642
푂1 who is vaccinated immediately becomes ‘recovered’ and immune to RSV infection until her643
immunity waned. Immune response provoking vaccination was offered to all O1s in households644
when a birth occurred, as an addendum to the antenatal contact between mothers-to-be and health645
professionals. In principle, there were three dimensions to the coverage of the immunity provoking646
vaccine: (i) coverage of households, (ii) coverage within households, and (iii) vaccine effectiveness.647
For simplicity, we bundled these dimensions together, and vaccinated whole households at an648
effective vaccination coverage (the product of the three dimensions of coverage). Over 10 years649
of forecasted RSV epidemics if a MAB vaccine was available, and given to every pregnant mother,650
8,601 MAB vaccines were deployed each year. 0 - 24,095 IRP vaccines were deployed each year651
depending on household coverage. It should be noted that by 2016 the KHDSS population was652
around 240,000 people, hence 100% effective coverage of the households where births occurred653
corresponded to ∼10% effective coverage of the total population.654
Model simulations655
We simulated the model by numerically solving the high dimensional ODE [equation (51)] simultane-656
ously with the ongoing cumulative hospitalisations in each age category, ̇푎 = ℎ푎푎(푡), which allowed657 us to solve for the model predicted weekly hospitalisations [equation 7]. The initial state of the658
model was unknown. We initialised the model by starting with a completely susceptible population659
with the population demography set to mimic that of the KHDSS on 1st Jan 2000. We then simulated660
RSV transmission for 10 years, with demographic rates (e.g. birth rates) chosen to match those of661
KHDSS in year 2000 and the seasonal amplitude and phase of ln 훽 set to their latest mean estimate,662
in order to provide an initial state of the household model. Finally, we ran the model from 1st Jan663
2000 until 1st September 2001. This provided the initial point for comparison to hospitalisation664
data. Numerical solutions were provided using the Sundials CVODE solver Cohen et al. (1996) im-665
plemented within the DifferentialEquations package for Julia 0.6 Rackauckas and Nie (2017). For666
retrospective simulations comparing model predictions to data (Fig. 2) we used the most probable667
values of the yearly seasonality. For forecast simulations we generated 500 realisations of yearly668
seasonality over 10 years from the distribution inferred in model inference, this gave 500 predictions669
for the time series of future hospitalisations. We typically presented medians of these predictions670
(e.g. Fig. 4). The code for the RSV household model used in this paper, and the data used for671
parameter inference, is available from https://github.com/SamuelBrand1/RSVHouseholdModel.git672
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Appendix 1816
Modelling seasonality in RSV transmission among KHDSS817
RSV is a seasonal virus, in temperate climates the peak month for RSV incidence tends to
be consistent year-on-year. Therefore, modelling approaches aimed at understanding RSV
transmission in temperate climates have used an annually periodic deterministic function,
with the timing of peak infectiousness of RSV being either a model parameter Yamin et al.
(2016) or itself a function of climatic variable to be fitted using regression methods Pitzer
et al. (2015).
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The seasonal drivers of RSV transmission in the tropics are less clear Paynter (2015). At
KCH the most common trough month for RSV hospitalisations was September, which lead
us to define the RSV ‘year’ as September - September. The most common month for peak
hospitalisation in each RSV year was January, however there was significant variation in peak
month between RSV seasons with peaks occurring in each month November - April between
2002-2016 (Appendix 1 Fig 1).
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Figure 1. Distribution of peak month for RSV hospitalisations at KCH.8312
The year-on-year variation in peak month for RSV hospitalisation means that naively
inferring a single fixed peak infectiousness parameter would not be a successful inference
strategy. However, determining the precise mechanistic reason for shifting seasonality was
challenging for the KHDSS population. RSV has been positively associated with the rainy
season in some tropical settings Paynter et al. (2012); Paynter (2015), however this is not
obviously the case in Kilifi county where the rainy season is April to June with short rains
October to December. There have been many proposed mechanisms for erratic periodicity
in transmission (for a wide variety of infectious pathogens) which could be relevant to RSV
transmission in Kilifi, for example, dynamical attractor switching Keeling et al. (2001), or
the effect of species/strain interaction Bhattacharyya et al. (2018). In particular, strain
competition between RSV A and RSV B has been identified a mechanism for generating
complex seasonal dynamicsWhite et al. (1999).
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In this paper, we took an agnostic view and rather than choosing a mechanistic hy-
pothesis for erratic seasonality from the many possible, we assume that the time-varying
infectiousness of RSV alters randomly (but from a common distribution) year to year:
ln 훽(푡) = 휉푛 cos(2휋(푡 − 휙푛)), 푡 ∈ RSV year 푛. (10)
Where the RSV infectiousness (휉푛) and seasonal peak timing (휙푛) for each RSV year 푛 are
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drawn jointly from a normal distribution common to each year (휉푛, 휙푛) ∼  (흁,횺). Duringmodel inference the yearly 휉푛 and 휙푛 realisations are treated as latent variables; their meanand covariance matrix are imputed along with other model parameters.
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Appendix 2855
Household- and age-structured RSV transmission model details856
As described briefly in the main text, we developed a dynamic model for simulating the
spread of RSV through the KHDSS population. Themodel was a hybrid between amechanistic
ODE approach, this included detailed household structure but only a simplified set of age-
and-disease states for individuals within the households, and a data-driven empirical model,
this used the observed joint distributions of KHDSS individuals’ household occupancy and
ages to generate conditional predications of individual detail beyond that of the mechanistic
part of the model.
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Brief comparison to age-structured RSV transmission models864
A commonly used conceptual framework for modelling epidemic transmission with a pop-
ulation is the compartmental model Anderson and May (1992); Keeling and Rohani (2008);
each person’s disease state is described as being one of a finite number of possibilities,
e.g. susceptible, infectious, recovered, which define that person’s risk of contracting the
infectious pathogen or transmissibility whilst infected with the pathogen. Additionally, it is
usually important to capture the heterogeneity of the population, also called the population
structure, in contrast to unstructured populations where every individual is treated as inter-
changeable. Therefore, each person will be described by their position in the population
with sufficient detail that a rate of contact can be modelled between any pairs of individuals,
see Diekmann and Heesterbeek for a more detailed discussion on modelling population
structure Diekmann and Heesterbeek (2000). RSV transmission models have most com-
monly used age structure to describe heterogeneity in the population; each individual is
described jointly by their disease state and which age interval (from some predetermined
set of intervals) they occupy Pitzer et al. (2015); Kinyanjui et al. (2015); Yamin et al. (2016).
For age-structured RSV transmission models there are two dynamical elements: the trans-
mission of disease and the demographic turnover of the population (births, deaths and
ageing). At the level of the individual these are modelled as discrete random events occurring
at some per-capita rate Rock et al. (2014). However, for large populations, there will be a
very large number of individuals in each age-and-disease state, and the flux of population
density in each age-and-disease state converges in probability onto the solution of a set
of ordinary differential equations (ODEs) as the population size is treated as converging
to infinite size Kurtz (1970, 1971); Diekmann and Heesterbeek (2000). The limiting ODE
model has as many degrees of freedom as there are age-and-disease state combinations
in the epidemic model. In most epidemic modelling studies it is the deterministic evolu-
tion of the solution to these ODEs that is usually given as the transmission model description.
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In this paper, the essential modelling concept was to shift the focus away from numbers
of individuals in each age-and-disease state and towards the number of households in
each possible household configuration. A household configuration describes the number of
individuals in each age-and-disease state who cohabit within a single household. Including
households within the model adds a potentially relevant layer of realism; the social contacts
within a household are persistent, therefore pairs of individuals that cohabit will repeatedly
have the opportunity to infect one another if RSV enters the household but be relatively
cocooned from infection if RSV has not entered the household. Age-structured transmission
models implicitly assume that no two individuals contact one another more than once.
To see this consider a population size of 푁 ; the rate of any individual contacting another
single individual is (1∕푁) therefore the probability that an individual selects the same other
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individual twice for contact over any finite time horizon goes to zero as 푁 → ∞ (which is
also the limit at which the ODE model is valid). For household models the discrete random
events that change the state of individuals (infection, death etc.) also change the household
configuration. When the number of households is very large, there will be a large number of
households in each possible household configuration and, as with age-structured models,
there is convergence onto a set of ODEs with as many degrees of freedom as the number of
possible household configurations.
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The possible household configurations, or state space, of a household- and age-structured
RSV transmission model is considerably larger than it would be for the equivalent age-
structured model. If there are 푚 possible age-and-disease states then the number of possible
household configurations for a household of size 푛 is given by a standard combinatorial
identity, (푛+푚−1
푛
). In thus paper we consider a range of household sizes up to a maximum size
푛푚푎푥, therefore the number of household configurations was,
# household configurations = 푛푚푎푥∑
푛=1
(
푛 + 푚 − 1
푛
)
.
The number of possible household configurations grows very rapidly (appendix 2 Fig. 1).
Therefore, having a sufficiently large 푛푚푎푥 to capture the target population required using arelatively simple compartmental age-and-disease state model for RSV infection.
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Figure 1. Growth in number of possible household configurations as complexity of the underlyingage-and-disease state model grows. Calculated for a maximum household size of 10.9239245
Derivations for equilibriumbehaviour of unstructured RSV transmissionmod-
els
926
927
The age-and-household structured model we used in the main paper to make predictions
of potential vaccine effectiveness in a population with persistent social structure. However,
it can be useful to compare comparatively complex simulation studies to simpler models
which are at least partially analytically tractable; this comparison identifies which features of
a model are generic as opposed to emerging frommore complicated factors (like seasonality
or social structure).
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A simple unstructured compartmental model of RSV transmission with two types of
vaccine in a population of size 푁 was presented in the main paper (Box 1). Individuals
are born into the population at rate 퐵 and are initially protected against RSV by maternal
antibodies (푀). All individuals die at rate 휇. They lose maternal protection at rate 훼푣푎푐 (therate associated with the maternal vaccine) and become susceptible to RSV infection (푆).
Each susceptible is infected at a rate 훽퐼∕푁 where 훽 is the product of the contact rate and
the probability of transmission per contact and 퐼 is the number of infected individuals in
the population. Infected individuals clear their infection and become recovered and are
temporarily immune to reinfection (푅) at rate 훾 . Recovered individuals lose their temporary
immunity to reinfection at rate 휈. A vaccine aimed at provoking an immune response akin
to a natural infection (IRP vaccine) is also used to control RSV. This is given to individuals
in the population at effective rate 푉 (rate of delivery times probability the vaccine dose is
successful). For simplicity, we assume that the IRP vaccine is not given to children so young
they are likely to be in the푀-compartment, but their isn’t memory of which individuals have
been vaccinated recently, therefore the chance that an individual selected for vaccination is
actually susceptible is 푆∕(푆 + 퐼 + 푅). If a susceptible individual is vaccinated she transitions
to becoming temporarily immune to RSV, this temporary immunity being lost at rate 휈.
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The ODE equations for the dynamics of the basic unstructured model are:
푀̇ = 퐵 − 훼푣푎푐푀 − 휇푀, (11)
푆̇ = 훼푣푎푐푀 −
훽
푁
푆퐼 + 휈푅 − 휇푆 − 푉 푆
푆 + 퐼 + 푅
, (12)
퐼̇ = 훽
푁
푆퐼 − 훾퐼 − 휇퐼, (13)
푅̇ = 훾퐼 + 푉 푆
푆 + 퐼 + 푅
− 휇푅 − 휈푅. (14)
We solve for the equilibrium state of this simple model, denoted (푀∗, 푆∗, 퐼∗, 푅∗), assuming
that the population has reached a steady size of 푁 , with replacement birth rate 퐵 = 휇푁 . For
the simple RSV model we use a mortality rate 휇 that corresponds to a life expectancy of 65
years, the Kenyan average. The reproductive ratio for the model is 푅0 = 훽∕(훾 + 휇).
952
953
954
955
956
957
958
959
Since, the rate of loss of maternal immunity is fast compared to the mortality (훼푣푎푐 ≫ 휇)nearly all the population survive their푀 period and become available for infection,
푆∗ + 퐼∗ + 푅∗ =
훼푣푎푐
훼푣푎푐 + 휇
푁 ≈ 푁. (15)
We use 푆∗ + 퐼∗ + 푅∗ = 푁 below to simplify the notation, but 푁 could be replaced with
푁푒푓푓 =
훼푣푎푐
훼푣푎푐+휇
푁 . Note that the maternal vaccine doesn’t alter the incidence rate for the simple
RSV model at equilibrium, it simply delays the typical infection time. Equation (13) implies
that either 퐼∗ = 0 (disease free state), or,
푆∗ = 푁
푅0
. (16)
Therefore,
푅∗ = 푁(1 − 1∕푅0) − 퐼∗. (17)
Combining equations (12), (15), (16), (17) gives that if RSV is endemic then,
퐼∗ = max
{ 1
훾 + 휇 + 휈
(
(휇 + 휈)푁(1 − 1∕푅0) − 푉 ∕푅0
)
, 0
}
. (18)
Equation (18) implies that for the simple RSV model the critical rate at which an IRP vaccine
eliminates RSV is 푉푐 = (휇 + 휈)푁(푅0 − 1).
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At an endemic equilibrium, the RSV incidence rate with vaccination rate 푉 , denoted 휄∗푉 , istherefore,
휄∗푉 =
훽푆∗퐼∗
푁
= 1
(훾 + 휇 + 휈)푅0
(
(휇 + 휈)푁(훽 − 휇훾) − (훾 + 휇)푉
)
= (훾 + 휇)
(훾 + 휇 + 휈)푅0
(
(휇 + 휈)푁(푅0 − 1) − 푉
)
. (19)
Equation (19) implies the two results which are presented in Box 1 of the main text:
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• The relative reduction in incidence due to IRP vaccination compared to no vaccination
is,
휄∗0 − 휄
∗
푉
휄∗0
= min
{ 푉
푁(휇 + 휈)(푅0 − 1)
, 1
}
. (20)
In this paper, we model a scenario where co-habitants of newborn children each
receive an IRP vaccine. This fixes 푉 to be proportional to the birth rate, 푉 = 휇푁⟨퐻⟩푉푐표푣,where ⟨퐻⟩ is the average number of co-habitants that a newborn has and 푉푐표푣 is theeffective IRP coverage of households. This gives,
Relative reduction in transmission due to vaccination = min{ 휇⟨퐻⟩푉푐표푣
(휇 + 휈)(푅0 − 1)
, 1
}
.
(21)
988
989
990
991
992
993
994
995
996
997
998
999
• Whilst RSV is not eliminated the reduction in incidence rate due to IRP vaccination is
linear in 푉 , with the improvement per extra vaccine used being a constant
Reduction in transmission per IRP vaccine = (훾 + 휇)
(훾 + 휇 + 휈)푅0
. (22)
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The mean number of over-one year olds living in households with at least one under-one
year old in the KHDSS (see below) fluctuated yearly, but was never greater than five (⟨퐻⟩ < 5).
Therefore, using a reversion to susceptibility rate 휈 = 2 per year (see main table 2) with
equation (21) suggests that if, say, 푅0 = 2 then the maximum achievable relative reductionin RSV incidence using this strategy with a Kilifi like population implied by the simple RSV
model is 3.8%.
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Age-and-disease states for the household model1011
A literature review of mechanistic RSV transmission models revealed a number of critical
common features:
1012
1013
• At birth newborns are born protected against RSV infection due to antibodies gained
from their mother via trans-placental transfer. This is typically modelled as a maternally
protected disease state푀 e.g. Yamin et al. (2016).
1014
1015
1016
• The probability of developing severe disease and being hospitalised depends on a
person’s age, and number of times infected in the past, e.g. Kinyanjui et al. (2015).
1017
1018
• The susceptibility to RSV infection per infectious contact, their infectiousness after
infection, and the expected time taken to become recovered from RSV depend on
number of times previously infected, e.g. Kinyanjui et al. (2015).
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1021
The high dimensionality of household- and age-structured models necessitated using the
most minimal age-and-disease state model possible for RSV (see above). To do this we use
an extremely parsimonious approach. The possible age-and-disease state for individuals are:
susceptible or maternally protected and under the age of one (푆1), infectious and under theage of one (퐼1), recovered and under the age of one (푅1), susceptible and over the age of one(푆2), infectious and over the age of one (퐼2) and recovered and over the age of one (푅2). An
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under-one year old (U1) experiencing some force of infection 휆 becomes infected (푆1 → 퐼1)and infectious to RSV at a rate 휎푈1휆 where 휎푈1 is the average susceptibility of an U1 year oldto RSV. After becoming infected the U1 ceases to become infectious at a rate 훾1 (퐼1 → 푅1)and then is immune to reinfection to RSV for a period of time. The immunity derived from
natural infection is lost at a rate 휈, and the U1 revert to susceptibility but in the 푆2 category(푅1 → 푆2). The reason we transition recovered U1s to a susceptible over-one year old (O1) isthat due to the seasonality of RSV it is very rare for a person to be infected more than once
in one epidemic season, therefore functionally by the time an individual is facing the risk of
their second RSV lifetime infection they will very likely be over one. All U1s age at the rate
휂 = 1∕365.25 days−1 becoming individuals in the same disease state but over-one (푆1 → 푆2,
퐼1 → 퐼2, 푅1 → 푅2). An O1 individual experiencing a force of infection 휆 becomes infectedand infectious (푆2 → 퐼2) with RSV at a rate 휎푂1휆 where 휎푂1 is the relative susceptibility of O1scompared to an U1 no longer protected by maternal antibodies. Infectious O1s cease being
infectious (퐼2 → 푅2) at a faster rate than U1s, 훾2 > 훾1, but revert to susceptibility (푅2 → 푆2) atthe same rate 휈 (appendix 2 Fig. 2).
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As mentioned in the main document we relate this simple age-and-disease state model
to more complicated RSV models by (i) using the conditional age distribution of individuals to
address questions that required a more complicated age structure than a simple under/over-
one binary choice, for example whether susceptible under ones were still protected by
maternal antibodies, and (ii) by assuming that all over-ones have been infected at least once
and all susceptible U1s have never been infected andmight still be protected by maternal
antibodies.
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Figure 2. Schematic diagram of the basic age-and-disease state compartmental model for theindividuals inside the households.105110523
Household- and age-structured model dynamics1054
A household configuration is a tuple of the number of individuals in each age-and-disease
state who cohabit a household. The generic household configuration is denoted ℎ =
(푠1, 푖1, 푟1, 푠2, 푖2, 푟2), indicating that the household has precisely 푠1 individuals in state 푆1, 푖1individuals in state 퐼1 etc. The household size is the number of people living in the household(i.e. 푠1 + 푖1 + 푟1 + 푠2 + 푖2 + 푟2). We denote the space of possible household configurations Σand number of households in the state ℎ at time 푡 as퐻ℎ(푡). It is useful to consider a vectorquantity over all possible household configurations such as 푯(푡) = (퐻ℎ(푡) | ℎ ∈ Σ) where
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we have generated some ordering for elements ℎ ∈ Σ. It is clear that the knowledge of
(푯(푡), 푡 ≥ 0) would allow us to reconstruct the dynamics of individuals. For example, using
the function 푓 (ℎ) = 푠1 for each ℎ ∈ Σ in a vectorised form 풇 = (푓 (ℎ) | ℎ ∈ Σ) allows us to trackthe dynamics of numbers of 푆1 individuals: (풇 ⋅푯(푡), 푡 ≥ 0).
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
As mentioned above, age-structured models are constructed by considering the per
capita rate of events affecting the state of individuals. Household- and age-structured
models are constructed by considering the per household rate of events that affect the
household configuration (see House and Keeling (2008) for further mathematical details). In
the following we list the events that change the household model divided into three groups:
events due to transmission within the household, events due to transmission between
households and events due to demographic turnover.
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Events due to RSV transmission within the household1073
• Infection of susceptibles from within the household:
For U1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 − 1, 푖1 + 1, 푟1, 푠2, 푖2, 푟2] at rate: 휎푈1훽(푡)휏푠1(푖1 + 휄2푖2), (23)
For O1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1, 푖1, 푟1, 푠2 − 1, 푖2 + 1, 푟2] at rate: 휎푂1훽(푡)휏푠2(푖1 + 휄2푖2). (24)
휏 is the household infection rate, 휄2 is the reduction in infectiousness due to being anO1, 훽(푡) is the seasonally varying component to the transmission rate and 휎푂1 is thereduction in susceptibility due to being O1. Note that the true infection rate for U1s
is 휎푈1휆ℎℎ and for O1s is 휎푂1휆ℎℎ as defined in main text. 휎푈1 is the probability that anU1 individual is no longer protected by maternal antibodies, calculated by integrating
over the individuals conditional age distribution as follows. Maternal protection was
assumed to be 100% effective but only for a random duration per newborn of푀 days,
therefore using the uniform age distribution conditional on the individual being under
one years old (see above),
휎푈1 =
1
푇 ∫
푇
0
ℙ(푀 ≤ 푎) d푎. (25)
Where 푇 is the duration of a year expressed in the units of the simulation (we used days
so 푇 = 365.25 days). The probabilistic model for the duration of maternal protection
was 푃 ∼ exp(훼)|푀 ≤ 푇 days , where 훼 is the waning maternal immunity rate. The
distribution function for푀 is
ℙ(푀 ≤ 푎) =
{
(1 − exp(−푎∕푀̄))∕(1 − exp(−푇 ∕푀̄)) 0 ≤ 푎 ≤ 푇
1 otherwise (26)
Where 푀̄ = 1∕훼 is the mean period of maternal protection without conditioning on
푀 ≤ 푇 , the true mean period of protection is 피[푀] = 푀̄ − 푇 ∕(푒푇 ∕푀̄ − 1) but this turns
out to be a very small correction to푀 since we fit to푀 being less than 30 days (see
below), therefore for simplicity we call푀 the mean duration of maternal protection to
RSV. Substituting into equation (25) and direct integration gives,
휎푈1 =
1
1 − 푒−푇 ∕푀̄
− 푀̄
푇
. (27)
Note that 휎푈1 ≈ 1 − 푀̄∕푇 when 푀̄ ≪ 푇 .
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• Recovery of infecteds:
For U1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1, 푖1 − 1, 푟1 + 1, 푠2, 푖2, 푟2] at rate: 훾1푖1, (28)
For O1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1, 푖1, 푟1, 푠2, 푖2 − 1, 푟2 + 1] at rate: 훾2푖2. (29)
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Where 훾1 and 훾2 are the recovery rates of U1s and O1s.
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• Reversion to susceptibility:
For U1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1, 푖1, 푟1 − 1, 푠2 + 1, 푖2, 푟2] at rate: 휈푟1, (30)
For O1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1, 푖1, 푟1, 푠2 + 1, 푖2, 푟2 − 1] at rate: 휈푟2. (31)
Where 휈 is the reversion to susceptibility/waning immunity rate.
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Events due to RSV transmission from without the household1116
In a purely age-structured transmission model the number of RSV infecteds in each age
category, 푰(푡) = (퐼푎(푡))푎∈, is a dynamic model variable which evolves according to a set ofODEs. For the household- and age-structured model we derived 푰(푡) from the household
configuration dynamics and the conditional age distributions as the expected number of
infecteds in each category given the distribution of household configurations푯(푡). Note that
knowing a household configuration specifies both the household size 푛 = 푠1+푖1+푟1+푠2+푖2+푟2and the under-one occupant boolean 푈 = ퟏ(푠1 + 푖1 + 푟1 > 0). Therefore, we could define a|| × |Σ| conversion matrix to convert between the dynamic푯(푡) variables into the implied
푰(푡) variables,
푃퐻→퐴,푡 = (ℙ푡(푎|ℎ))푎∈,ℎ∈Σ, (32)
푰(푡) = 푃퐻→퐴,푡푯(푡). (33)
The age dependent force of infection on each individual in age category 푎, 휆푎푔푒(푎) dependson a community age mixing matrix 푇 = (푇 (푎, 푏))푎∈,푏∈,
휆푎푔푒(푎, 푡) =
∑
푏∈
푇 (푎, 푏)[ퟏ(푎 < 1 year) + 휄2ퟏ(푎 > 1 year)]퐼푏(푡)∕푁(푡). (34)
Where 푁(푡) is the total population size at time 푡. This is a standard formulation for force of
infection between different age groups (see Keeling and Rohani Keeling and Rohani (2008)).
In principle any age-mixing matrix can be used as 푇 , however we use a simple matrix in
block form that differentiated only between U1s, O1s of school age, and all other O1s (see
main text). The force of infection on U1 and O1 individuals within households was calculated
using a |Σ| × || conversion matrix, and a small force of infection from outside the KHDSS
was added, 휖,
푃퐴→퐻,푡 = (ℙ푡(ℎ|푎))ℎ∈Σ,푎∈, (35)
휆푐표푚(푈1, ℎ, 푡) =
∑
푎<1 year
ℙ푡(ℎ|푎)휆푎푔푒(푎, 푡) + 휖∕푁(푡), (36)
휆푐표푚(푂1, ℎ, 푡) =
∑
푎>1 year
ℙ푡(ℎ|푎)휆푎푔푒(푎, 푡) + 휖∕푁(푡). (37)
The external infection event changes the household configuration:
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• Infection of susceptibles from outside the household:
For U1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 − 1, 푖1 + 1, 푟1, 푠2, 푖2, 푟2] at rate: 휎푈1훽(푡)푠1휆푐표푚(푈1, ℎ, 푡), (38)
For O1s: [푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1, 푖1, 푟1, 푠2 − 1, 푖2 + 1, 푟2] at rate: 휎푂1훽(푡)푠2휆푐표푚(푂1, ℎ, 푡). (39)
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Events due to demographic change in the population1149
In the household-and-age-structured RSV model we track demographic change both by using
the yearly updated joint distributions of age and household size and by the dynamics of the
household configurations푯(푡). The number of households of each size 푛 changed over time
due to the effect of people leaving home, births, deaths, out-migration from KHDSS and
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in-migration into KHDSS. Moreover, the mean number of U1s per household of each size
evolved over time. Rather than track all the possible events that change the demography of
the KHDSS, we focus on (i) the ageing of the U1s becoming O1s, (ii) capturing the household
size dependent birth rate, and (iii) capturing the change in household numbers for each
household size.
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The recorded birth rate that can be inferred from the KHDSS data set included newborns
who out-migrate, neglected newborns that in-migrate at a very young age, and obviously
some newborns die whilst very young. As mentioned above, we did not mechanistically track
every possible demographic event, but instead calculated the effective birth rate that arrived
at the correct mean number of U1s for each household size. For simplicity, we assumed that
the effective birth rate was a turnover rate for households; that is each birth is associated
with a per-capita rate of an O1 leaving the household. This arrived at the correct density of
U1s in the population, and in each size group of households, at the cost of assuming that
events occurred at the same time rather than at the same rate.
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The number of households of each size changed over time as the overall population
size changed and individuals left households in order to form new households. As with
the demographic turnover rate, there were multiple different mechanisms whereby new
individuals entered the population and formed new houses or individuals and groups left
the population, e.g. whole groups arrived and formed a new house, individuals arrived
and joined houses etc. Moreover, the RSV infection status of the new entrants to the
population were unknown. We assumed that new entrants arrived as households with
the same distribution of household configurations as already observed in the population;
that is that new arrivals didn’t have a net effect on the proportion of individuals in each
age-and-disease state just by arriving, although obviously as the population grew this has an
effect of the number of hospitalisations we expected.
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The demographic events that changed the household configurations were:1179
• Aging:
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 − 1, 푖1, 푟1, 푠2 + 1, 푖2, 푟2] at rate: 휂푠1, (40)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1, 푖1 − 1, 푟1, 푠2, 푖2 + 1, 푟2] at rate: 휂푖1, (41)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1, 푖1, 푟1 − 1, 푠2, 푖2, 푟2 + 1] at rate: 휂푟1. (42)
Where 휂 = 1∕푇 is the aging rate at which U1s become O1s. 푇 is the duration of a year
expressed in the units of the simulation (we used days so 푇 = 365.25 days).
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• Demographic turnover due to births and O1s leaving their household:
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 + 1, 푖1, 푟1, 푠2 − 1, 푖2, 푟2] at rate: 휇(푛, 푡)푠2, (43)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1 + 1, 푖1, 푟1, 푠2, 푖2 − 1, 푟2] at rate: 휇(푛, 푡)푖2, (44)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 + 1, 푖1, 푟1, 푠2, 푖2, 푟2 − 1] at rate: 휇(푛, 푡)푟2. (45)
If there is at least one O1 left in the household, the birth/turnover rate is zero for
households with only 1 O1; that is there are never any households of only U1s. 휇(푛, 푡)
is the turnover rate per O1 household member in a household of size 푛 at time 푡
replacing them with susceptible U1s for households of size 푛. The turnover rates for
each year were chosen so that the correct density of U1s per household was achieved
(approximately). Following is a description of the fitting process so that the turnover
rate lead to this household demography:
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
33 of 49
Manuscript submitted to eLife
1. Collect the empirical distribution of U1s per household size. For each household size
푛 = 1,… , 푛푚푎푥 we calculated the mean number of U1s per household at 푦 = 1st jan2000-2017, this was denoted: 푁푈1(푛, 푦).
1197
1198
1199
2. Calculate the implied distribution of U1s per household size for any given birth/turnover
rate. For any given birth/turnover rate, 휇, the equilibrium probability of finding 푘
U1s in a household of size 푛 is
휋(푘|푛, 휇) ∝ (휇
휂
)푘(푛
푘
)
푘 = 0, ..., 푛 − 1, (46)
휋(푛|푛, 휇) = 0. (47)
Equation (46) is just the equilibrium distribution of a birth-death processGrimmett
and Stirzaker (2001).
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3. Matching the empirical distribution to the implied distribution. We used a root-finder
to find the turnover rate that matches the simulation’s mean number of U1s per
household of each size to the empirical data, for the next year:
휇(푛, 푡) is the solution to 푛−1∑
푘=0
푘휋(푘|푛, 휇(푛, 푡)) = 푁푈1(푛, 푦 + 1) for all 푡 in year 푦. (48)
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• Change in number of households due to population flux1214
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ 2[푠1, 푖1, 푟1, 푠2, 푖2, 푟2] at rate: 푟(푛,푡)∑
ℎ∈Σ푛 퐻ℎ(푡)
, if 푟(푛, 푡) ≥ 0, (49)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ ∅ at rate: |푟(푛,푡)|∑
ℎ∈Σ푛 퐻ℎ(푡)
, if 푟(푛, 푡) < 0. (50)
Where, Σ푛 = {ℎ = [푠1, 푖1, 푟1, 푠2, 푖2, 푟2] | 푠1+ 푖1+ 푟1+ 푠2+ 푖2+ 푟2 = 푛} was the set of householdconfigurations of households of size 푛. 푟(푛, 푡) was the daily rate of change of number of
households of size 푛 interpolated between the empirical distribution dates.
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Simulating the model1222
The model above could in principle have an infinite number of states if the household size
was not limited (see above). We chose limits on the household size based on capturing ≈
99% of the U1s in the population, and therefore the pathway to them catching RSV. The
limits were: (i) no household is bigger than size 10, and (ii) no household has more than 2
U1s. This also covers the big majority of the total numbers of households (see appendix
2 Fig 3). The 푛푚푎푥 = 10 limit was imposed by initialising the model without households ofsize > 10, and setting 푟(푛, 푡) = 0 for all 푛 > 10. The ≤ 2 U1 limit was imposed by setting the
birth/turnover rate to zero for all households with 2 U1s. Putting the limits in reduces the
dimensionality of the system to 1926 different household configurations.
1223
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1226
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1232
Figure 3. Household occupancy characteristics calculated on each 1st Jan 2000-2017. Top: Percentageof U1s in households of a certain size or smaller. Middle: Percentage of U1s in households with only oneU1 and households with one or two U1s. Bottom: Household size distribution.
1233
1234
12356
Note that the events that either change a household’s configuration or change the
number of households described above can be divided into two categories: [1] those
with rates that only depended on the household’s configuration, e.g. infection within the
household, or ageing of U1s, and, [2] those with rates that depended on the configurations of
other households, e.g. transmission between households or the rate of change of household
numbers. The events in category [1] translate to linear dynamics for푯(푡), events in category
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[2] translate to non-linear dynamics House and Keeling (2008). Overall, the dynamics of푯(푡)
obey the semi-linear dynamical system,
푯̇(푡) = 퐴푡푯(푡) + 풇푡(푯(푡)) + 흆푡(푯(푡)). (51)
퐴푡 is a matrix which encodes the dynamics of events in category [1], 풇푡(푯(푡)) encodes thetransmission between households, and 흆푡(푯(푡)) encodes the rate of change of numbers ofhouseholds in each configuration. We initialised the dynamics of equation (51) by starting
with a completely susceptible population on 1st Jan 1990, allowing RSV to be introduced via
the external force of infection and running for 10 years (see main text).
1237
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Equation (51) has two properties that are important to note:1253
• The change rate in households of size 푛 is independent of the transmission dynamics:
휕푡
( ∑
ℎ∈Σ푛
퐻ℎ(푡)
)
= 푟(푛, 푡), 푛 = 1,… , 10. (52)
1254
1255
1256
1257
• The dynamics of the proportion of households in a given state 푃ℎ(푡) = 퐻ℎ(푡)∕∑ℎ′ 퐻ℎ′ (푡)is not directly affected by the change rates (흆푡) in households:
휕푡푷푡 = 퐴푡푷푡 +
풇푡
(
푯푡
)
∑
ℎ′ 퐻ℎ′ (푡)
(53)
1258
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Equations (52) and (53) guarantee the desired modelling features discussed above. Equation
(52) gives that the change in the number of households of each size matches the empirical
rate of change for each year, we also verified this by numerical solution of equation (51)
(appendix 2 Fig 4). Equation (53) shows that the rate of change of household numbers
doesn’t directly effect the proportion of households in any given configuration. We also
verified that the number of U1s and O1s was close to their empirical values (appendix 2 Fig
5).
1263
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Equation (51) was difficult to solve efficiently because it is both numerically stiff and high
dimensional. We numerically solved equation (51) using the Julia DifferentialEquations
package implementation of the CVODE solver, with an efficient Krylov method (GMRES) to
solve the implicit timestepping (see main text). We also used the DifferentialEquations
efficient event handling which allowed us to change parameters (like the household change
rate) at specific times without damaging the performance of the solver, or having to restart
simulations.
1270
1271
1272
1273
1274
1275
1276
36 of 49
Manuscript submitted to eLife
1277
Figure 4. Comparison of numbers of households of sizes 1-10 on each 1st Jan 2000-2017 (dots) againstsimulated values (curve). Simulation is from Sept 2001 - Sept 2016. Horizontal axis is days since 1st Jan2000.
1278
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1282
Figure 5. Comparison of total numbers of U1s and O1s on each 1st Jan 2000-2017 (dots) againstsimulated values (curve).128312845
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Appendix 31286
Parameters for the household- and age-structured RSV transmission
model
1287
1288
The parameters for the household- and age-structured transmission model were drawn
from four sources:
1289
1290
• A literature review of infectiousness duration and other epidemiological quantities;
main table 2.
1291
1292
• Calculated from the empirical joint distributions (see above); appendix 3 table 1.1293
• Age-dependent hospitalisation probability per RSV infection derived from Kinyanjui
et al Kinyanjui et al. (2015); appendix 3 table 2. Hospitalisation probability was the
probability that an infected individual would develop severe disease, multiplied by
the probability that severely diseased individuals would require hospitalisation. The
probability that an infected individual became diseased depended on whether it was
the individual’s primary infection episode or not. The underlying data for estimating
these probabilities was drawn from cohort studies on RSV disease rates Ohuma et al.
(2012); Nokes et al. (2008). We adapted these probabilities for our model using our
assumption that all infected under-ones were experiencing their first RSV episode, and
all over-ones were experiencing their second or subsequent infection.
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
• Inferred from the KCH hospitalisation data set (see below).1304
Table 1. Parameters estimated from KHDSS data.13056
Parameter Description Value Data source
휇(푛, 푡) Birth/turnover rate for households of
size 푛 on day 푡
Varies, see above KHDSS
푟(푛, 푡) Rate of change of numbers of house-
holds of size 푛 on day 푡
Varies, see above KHDSS
푃퐻→퐴,푡 Conditional age distribution givenhousehold config. on day 푡
Varies, see above KHDSS
푃퐴→퐻,푡 Conditional household config. distri-bution given age category on day 푡
Varies, see above KHDSS
1307
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Table 2. Age-dependent hospitalisation probabilities per infection derived from Kinyanjui et alKinyanjui et al. (2015).1308130910
Age category Probability of hospitalisation per infection
0-1 month 0.10
1-2 month 0.10
2-3 month 0.063
3-4 month 0.059
4-5 month 0.054
5-6 month 0.025
6-7 month 0.019
7-8 month 0.022
8-9 month 0.012
9-10 month 0.016
10-11 month 0.013
11-12 month 5.1x10−3
1-2 years old 2.6x10−3
2-3 years old 7.5x10−4
3-4 years old 2.2x10−4
4-5 years old 3.8x10−5
1311
Parameter inference for the household- and age- model1312
As mentioned in the main text we used the EM algorithm Dempster et al. (1977) to estimate
parameters for the model. Again, as described in the main text the parameters we chose for
inference were:
1313
1314
1315
• Infectious contact rate outside the household between U1s and all others in the
community accessing KCH (푏푈1).
1316
1317
• Infectious contact rate outside the household among all O1s in community (푏푂1).1318 • Infectious contact rate within the household (휏).1319
• Rate of loss of maternally derived immunity to RSV (훼).1320
• The joint normal distribution of the yearly log-seasonality amplitude and phase ([휉, 휙] ∼
 (흁,횺)).
1321
1322
Where the community age mixing matrix 푇 (푎, 푏) was in block form:
푇 =
⎛⎜⎜⎜⎝
푏푈1 푏푈1 푏푈1
푏푈1 푏푆 + 푏푂1 푏푂1
푏푈1 푏푂1 푏푂1
⎞⎟⎟⎟⎠ . (54)
The log-likelihood for our model [equation (8) main text] was defined using the incidence
rates 푎(푡) predicted by solving the model. The incidence rate for all the households in thegeneric household configuration was,
For U1s: ℎ(푈1, 푡) = (휎푈1훽(푡)푠1(휆ℎℎ + 휆푐표푚(푈1, ℎ, 푡)))퐻ℎ(푡) (55)
For O1s: ℎ(푂1, 푡) = (휎푂1훽(푡)푠2(휆ℎℎ + 휆푐표푚(푂1, ℎ, 푡)))퐻ℎ(푡). (56)
Where the household force of infection for the generic household configuration was
휆ℎℎ = 휏(푖1 + 휄2푖2). We converted the household incidence rate into an age structured in-cidence rate by using conditional age distributions, and this allowed us to calculate the
cumulative hospitalisations in age category 푎, predicted by a given set of parameters and
yearly seasonality realisations, in weekly intervals 푤푖 = (푡푖,1, 푡푖,2) using the age dependent
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hospitalisation rates per infection ℎ푎 (see table 2)
푎(푡) =∑
ℎ∈Σ
ℙ(퐴 ∈ 푎|푀 < 퐴,퐴 ≤ 1 year)ℎ(푈1, 푡) + ℙ(푎|ℎ,퐴 > 1 year)ℎ(푂1, 푡) (57)
(푎,푤푖) = 퐾(푡)∫
푡푖,2
푡푖,1
푎(푡)ℎ푎 d푡, (58)
lnℙ(푖,푎|휃, 흃,흓) = 푙(휃, 흃,흓) =∑
푖
∑
푎
ln 푓푝표푖(푖,푎|(푎,푤푖)). (59)
Here 퐾(푡) is a time-varying scale factor that accounted for the fact that whilst we were
modelling RSV infection for the KHDSS population, other individuals were accessing KCH
for treatment of RSV-induced severe disease. To fit 퐾(푡) we first performed a polynomial
regression 푅(푡) against the ratio of KHDSS members using KCH against non-KHDSS members
(appendix 3 Fig 1) t = 0 (days) is 22nd April 2002 fitted curve is R(t) = 1.24+ 0.00224 푡 - 2.45e-
6푡2+ 9.45e-10푡3 - 1.55e-13푡4 + 9.10e-18푡5. 푅(푡) = 푅(0) for 푡 < 0, and 푅(푡) took its final value for
times after 1st sept 2016. Having fitted the ratio, the scale factor was 퐾(푡) = (1 +푅(푡))∕푅(푡),
which we derived by assuming that non-residents were experiencing RSV hospitalisations at
proportionally the same rate as residents.
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351 Figure 1. Ratio of KHDSS residents to non-residents weekly accessing KCH for confirmed RSV treatment.Red curve is polynomial fit 푅(푡).135213534
The conditional age category of an U1 who has definitely been infected, where 푎 = (푎0, 푎1),
ℙ(퐴 ∈ 푎|푀 < 퐴,퐴 ≤ 1 year) = ퟏ(푎 ≤ 1 year)ℙ(푀 < 퐴|퐴 ∈ 푎)ℙ(퐴 ∈ 푎|푎 ≤ 1 year)
ℙ(푀 < 퐴|푎 ≤ 1 year)
= ퟏ(푎 ≤ 1 year)푎1 − 푎0 +푀(푒−푎1∕푀 − 푒−푎0∕푀 )
푇 (1 − 푒−푇 ∕푀 )휎푈1
(60)
1355
1356
1357
1358
An implication of expression (60) is that if 푎0 and 푎1 are both significantly less than푀 = 1∕훼then ℙ(퐴 ∈ 푎|푀 < 퐴,퐴 ≤ 1 year) ≈ 0; that is that, although we have assumed that the
conditional age of an U1 is distributed evenly over the first year of life, the conditional age
distribution of an U1 who has been infected is typically older than푀 . This allowed us to
extract information for inferring 훼 from the age distribution of hospitalised children at KCH
despite only using a crude U1/O1 age distinction in the mechanistic formulation of the
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household-and-age model. The log-likelihood 푙(휃, 흃,흓) [equation(59)] could be determined
for a given set of parameters and realisations of the yearly seasonal amplitude and phase
by solving the full ODE system numerically [equation (51)], and thereby also calculating
the weekly hospitalisations. 휃 represented the model parameters to be inferred, 흃 and 흓
were the vectors of the seasonal transmission model equation (10), and 푖, 푎 was the KCHhospitalisation data for the 푖th week in the 푎 age category.
1359
1360
1361
1362
1363
1364
1365
1366
1367
1368
1369
1370
The main difficulty in the inference for the unknown parameters 휃 was that the actual
realisations of 흃 and 흓 are not observed, therefore 푙(휃, 흃,흓) could not be calculated directly.
Instead, we use the EM algorithm to converge onto a maximiser of the marginal likelihood,
(휃) = ∫ ℙ(, 흃,흓|휃) d흃 d흓. The EM algorithm converges a sequence of parameter estimates
(휃(푛))푛≥0 towards a local maximum of the marginal likelihood by alternatively, 1) calculatingthe expected value of the log-likelihood over the conditional distribution of 흃 and 흓 given the
observed data  and the current estimate of the parameters, which we dub the 푄 function
[E step], and, 2) finding the parameters which maximised the 푄 function [M step]. We now
give details of how this was implemented for the specific model developed in this paper:
1371
1372
1373
1374
1375
1376
1377
1378
1379
• E step: The conditional distribution of 흃 and 흓 given the 푛-th parameter estimate
휃(푛), from the previous M-step, and  could not be calculated in closed form. In
principle, this distribution could have estimated numerically (e.g. by using a particle
filter method), however, because the household- and age-structured RSV transmission
model was comparatively slow to integrate (∼ 40 secs per simulation) we resorted to
saddle-point integration. Our argument is that because nearly every year has a sharply
peaked hospitalisation rate then, given a parameter estimate 휃(푛), the conditional
probability of (흃,흓) should be concentrated around a particular value, making saddle-
point integration an appropriate approximation (see Hinch (1991) for further details
on saddle-point integration). Using the saddle-point approximation we could solve for
the 푄 function,
푄(휃|휃(푛)) = 피흃,흓|,휃(푛) [lnℙ(, 흃,흓|휃)]
= 피흃,흓|,휃(푛) [푙(휃, 흃,흓) + lnℙ(흃,흓|휃)]
≈ 푙(휃, 흃∗,흓∗) + lnℙ(흃∗,흓∗|휃)
= 푙(휃, 흃∗,흓∗) −
∑
푖
[(휉∗푖 − 푚휉) (휙
∗
푖 − 푚휙)]횺
−1
휉휙[(휉
∗
푖 − 푚휉) (휙
∗
푖 − 푚휙)]
푇 + const.(61)
The approximation step in equation (61) is the saddle-point integration approximation
of the average, and the quadratic form is due to our assumption that the seasonal
amplitude and phases are distributed jointly normally. Saddle-point integration is
equivalent to assuming that the full mass of the conditional distribution of (흃,흓) was
concentrated at its most probable value,
(흃∗,흓∗) = argmax
흃,흓
lnℙ(흃,흓|, 휃(푛))
= argmax
흃,흓
{lnℙ(|흃,흓, 휃(푛)) + lnℙ(흃,흓|휃(푛))}
= argmax
흃,흓
{푙(휃(푛), 흃,흓) −
∑
푖
[(휉∗푖 − 푚
(푛)
휉 ) (휙
∗
푖 − 푚
(푛)
휙 )]횺
−1,(푛)
휉휙 [(휉
∗
푖 − 푚
(푛)
휉 ) (휙
∗
푖 − 푚
(푛)
휙 )]
푇 }.
(62)
We determined (흃∗,흓∗) by sequentially optimising equation (62) over each season by
simulating the model repeated and using the Nelder-Mead algorithm implemented
within theOptim package for Julia 0.6. Note that saddle point integration has converted
solving for the function 푄 into a regularised maximum likelihood problem where the
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regularisation was provided by the mean and covariance matrix for log-seasonal
amplitude and phase derived in the previous M step.
1380
1381
1382
1383
1384
1385
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1389
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1394
1395
1396
1397
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1400
1401
1402
1403
1404
1405
1406
1407
• M step: Having constructed the 푄 function associated with the 푛-th parameter iteration
[equation (61)], we maximised 푄 over 휃. The maximum point of 푄 being 휃(푛+1) for the
next E-step. Maximisation proceeded in three stages:
1408
1409
1410
1. The maximising values for the mean and covariance matrix of the random sea-
sonal amplitude and phase were given by maximum likelihood using (흃∗,흓∗)
derived in the E-step. This was performed using the fit_mle function provided by
the Julia Distributions package.
1411
1412
1413
1414
2. We performed a global optimisation for 푄 over a box in parameter space defined
by limits [0, 1] for transmission parameters and 1∕훼 =푀 ∈ [10, 120] days for the
inverse rate of loss of maternal immunity. Global optimisation was performed
by running 600 iterations of a differential evolution optimiser Storn and Price
(1997) with 50 agents. The differential evolution optimiser was implemented by
the adaptive_de_rand_1_bin_radiuslimited optimiser from the Julia BlackBox-
Optim package. The purpose of the global optimisation step was to reduce the
dependence on choosing an initial guess about 휃 since the whole plausibility space
of the parameters was explored at each iteration of the EM algorithm. We called
the best performing agent’s parameter set on the (푛 + 1)th step, 휃̃(푛+1).
1415
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3. We used 휃̃(푛+1) as the starting point for a further local optimisation of 푄 using
the Nelder-Mead algorithm implemented by the Julia Optim package. This step
provided 휃(푛+1) for the next E-step.
1425
1426
1427
We iterated EM algorithm until no further improvement in the value of 푄∗ = max휃 푄 wasachieved, and then retained 휃∗ = argmax휃 푄 as the maximum likelihood estimator for theparameters. 95% confidence intervals were estimated by using univariate profile likelihood
for 푄; that is varying one parameter at a time whilst keeping others fixed until a 휒2 region
was determined around the maximum of 푄 (see King et al for a description of 95% CIs for
dynamical systems King et al. (2008)).
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School mixing scenarios and inference results1434
We were unable to identify a mixing rate within schools 푏푆 , see equation (54), therefore weconsidered four values of 푏푆 each determined by what a baseline reproductive value for RSVwould be if only school children mixed together and the seasonality was just 훽(푡) = 1, 푅푆 ,using the simple formula,
푅푆 =
푏푆휎푂1휄2
훾2
(63)
These four scenarios were: zero schools transmission (푅푆 = 0), low schools transmission(푅푆 = 0.5), medium schools transmission (푅푆 = 1), and, high schools transmission (푅푆 = 1.5).We saw that once maximum likelihood estimation was performed on the free parameters:
휃 = (푏푈1, 푏푂1, 휏, 훼,풎,Σ휉휙) the resultant fits to the data were very similar visually (see appendix3 Fig 2). We noticed that the outcomes of vaccination were also similar for each four
scenarios (see below and figure 1). Therefore, for robustness of conclusion we used the
most pessimistic scenario within the main body of the paper, which was high schools
transmission 푅푆 = 1.5. The maximum likelihood estimates for parameters using the highschools transmission scenario are given in main table 3, and the maximum likelihood
estimates for all scenarios summarised in appendix 3 Fig 3.
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1448
1449
1450
1451
1452
1453
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Table 3. Model parameters inferred from hospitalisation data.14545
푏푈1 Community transmission rate forU1s
0.22 [0.18,0.27] per day
푏푂1 Community transmission rate forO1s
0.20 [0.18,0.21] per day
휏 Transmission rate to each other
member of household
0.040 [0.032, 0.048] per day
푀 Mean duration of maternal protec-
tion at birth
21.6 [17.2, 26.1] days
푚휉 Mean amplitude of log-seasonality 0.61 [0.51, 0.72]
푚휙 Mean timing of log-seasonalitypeak (phase)
67.7 [40.2, 77.7] days
휎휉 Std. amplitude of log-seasonality 0.20 [0.098,0.31]
휎휙 Std. timing of log-seasonality peak(phase)
38.7 [30.0, 48.5] days
휌휉휙 Corr. coefficient between log-seasonal amplitude and phase
-0.035 [-0.12, 0.072]
1456
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1457 Figure 2. Plots of fitted weekly hospitalisations and the age distribution of hospitalisations for fourscenarios (differing values of the schools based baseline 푅푆 ). In each case, parameter inference wasperformed and the maximum likelihood estimators used.
1458
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1462 Figure 3. Maximum likelihood parameters for the different school transmission rate scenarios. 푏푈1, 푏푂1are respectively the under-one and over-one mixing components of the community mixing rate matrix.
휏 is the rate at which a household member infectiously contacts each other household member.
푀 = 1∕훼 is the mean period of maternal protection after birth. 풎 = (푚휉 푚휙) is the mean vector of therandom seasonality, and 휎휉 , 휎휙 and 휌휉휙 are respectively the standard deviations of the seasonalamplitude, seasonal phase and the correlation between the two, derived from the estimated covariancematrix Σ휉휙.
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Appendix 41471
Modelling vaccination in the household- and age-structured RSV trans-
mission model
1472
1473
As described in the main paper we modelled the use of two different vaccines: a vaccine
deployed to boost the period during which a newborn is protected from RSV by an unknown
period 푃 with coverage 푉푐표푣 [MAB vaccine], and a vaccine deployed to O1 householdmembersof the newborn which provokes a period of protection to RSV infection similar to the immunity
period of a natural infection at household coverage퐻푐표푣 [IRP vaccine]. Already infected orrecovered O1s were not affected by the IRP vaccine. We assumed that the MAB and IRP
vaccines were deployed independently, which is useful for gauging potential effectiveness,
but unrealistic. In reality, any reason a mother-to-be might miss being MAB vaccinated would
also be a reason that the household O1s wouldn’t get vaccinated.
1474
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The IRP vaccine altered the effective birth events by also provoking transitions to 푅2 stateat the point of birth,
1483
1484
• Demographic turnover due to births with vaccination:
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1 + 1, 푖1, 푟1, 푠2 − 1, 푖2, 푟2] at rate: (1 −퐻푐표푣)휇(푛, 푡)푠2, (64)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 + 1, 푖1, 푟1, 푠2, 푖2 − 1, 푟2] at rate: (1 −퐻푐표푣)휇(푛, 푡)푖2, (65)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 + 1, 푖1, 푟1, 푠2, 푖2, 푟2 − 1] at rate: (1 −퐻푐표푣)휇(푛, 푡)푟2, (66)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2] → [푠1 + 1, 푖1, 푟1, 0, 푖2, 푠2 + 푟2 − 1] at rate: 퐻푐표푣휇(푛, 푡)(푠2 + 푟2), (67)
[푠1, 푖1, 푟1, 푠2, 푖2, 푟2]→ [푠1 + 1, 푖1, 푟1, 0, 푖2 − 1, 푠2 + 푟2] at rate: 퐻푐표푣휇(푛, 푡)푖2. (68)
1485
1486
1487
1488
The MAB vaccine altered both the probability that an U1 is protected, and the age
distribution of those who are infected. We denote the random period of time a newborn
born to a MAB vaccinated mother is protected from RSV as 푀푣푎푐 = 푀 + 푃 , which hasdistribution function,
ℙ(푀푣푎푐 ≤ 푎) =
⎧⎪⎨⎪⎩
0 0 ≤ 푎 ≤ 푃
(1 − exp(−(푎 − 푃 )∕푀̄))∕(1 − exp(−(푇 − 푃 )∕푀̄)) 푃 ≤ 푎 ≤ 푇
1 otherwise
(69)
The mean susceptibility of U1s after MAB vaccination has been applied to the population
was,
휎푈1,푣푎푐 =
1
푇 ∫
푇
0
(
(1 − 푉푐표푣)ℙ(푀 ≤ 푎) + 푉푐표푣ℙ(푀푣푎푐 ≤ 푎)) d푎
= 1 − 푀
푇
+ (1 − 푉푐표푣)푃
푒−푇 ∕푀
1 − 푒−푇 ∕푀
+ 푉푐표푣
(푇 − 푃 )푒−(푇−푃 )∕푀
푇 (1 − 푒−(푇−푃 )∕푀 )
− 푉푐표푣
푃
푇
. (70)
The conditional age category of an U1 who has definitely been infected, where 푎 = (푎0, 푎1),after MAB vaccine has been deployed at coverage 푉푐표푣 was,
ℙ(퐴 ∈ 푎|푀̃ < 퐴,퐴 ≤ 1 year) = ퟏ(푎 ≤ 1 year) ((1 − 푉푐표푣)ℙ(푀 < 퐴|퐴 ∈ 푎) + 푉푐표푣ℙ(푀푣푎푐 < 퐴|퐴 ∈ 푎))ℙ(퐴 ∈ 푎|푎 ≤ 1 year)
ℙ(푀 < 퐴|푎 ≤ 1 year)
=
ퟏ(푎 ≤ 1 year)
푇휎푈1,푣푎푐
(
(1 − 푉푐표푣)
푎1 − 푎0 +푀(푒−푎1∕푀 − 푒−푎0∕푀 )
1 − 푒−푇 ∕푀
+ 푉푐표푣푓 (푎, 푃 )
)
. (71)
Where 푀̃ is the random maternal protection duration of a newborn before we observe
whether the newborn’s mother had been MAB vaccinated. The function 푓 (푎, 푃 ) completes
equation (71) by giving the age distribution of U1s who had boosted maternal protection to
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RSV but was nonetheless infected,
푓 (푎, 푃 ) =
⎧⎪⎪⎨⎪⎪⎩
0 푎0 ≤ 푃 and 푎1 ≤ 푃
푎1−푃+푀(푒−(푎1−푃 )∕푀−1)
1−푒−(푇−푆)∕푀̄
푎0 ≤ 푃 and 푎1 > 푃
푎1−푎0+푀(푒−(푎1−푃 )∕푀−푒−(푎0−푃 )∕푀 )
1−푒−(푇−푆)∕푀̄
푎0 > 푃 and 푎1 > 푃
(72)
Note that because 휎푈1,푣푎푐 depended on 푉푐표푣 the age distribution of infected U1s dependedon 푉푐표푣 in a nonlinear fashion.
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We considered a range of values for 푃 and 퐻푐표푣 for each of the schools transmissionscenarios; using the maximum likelihood estimators for the inferred parameters for each
scenario. In each scenario, at 푉푐표푣 = 1 the median reduction in hospitalisations was similar,although for the high school transmission scenario vaccination was slightly less effective
(appendix 4 Fig 1/ Fig 2 colorblind-friendly version ). Therefore, we used this scenario in the
main paper as a pessimistic/robust example. As mentioned in main text we simulated 10
years into the future over 500 independent realisations of the random seasonality. Presented
are medians of % reduction in hospitalisations at KCH compared to no intervention.
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Figure 1. Vaccine effectiveness for the four school mixing scenarios at 100% MAB coverage.15245
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1526
Figure 2. Colorblind-friendly version of figure 4 frommain text. Forecast effectiveness of RSVvaccination for different mixed strategies over a 10 year period for 100% maternal vaccine effectivecoverage (A and C) and 50% maternal vaccine effective coverage (B and D). A and B: Percentagereduction in hospitalisations at KCH. C and D: Percentage reduction in total RSV infections in thepopulation.
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